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Abstract 
 
The Actinomycete Nonomuraea produces the glycopeptide A40926, precursor of 
dalbavancin, a novel lipoglycopeptide homologous to vancomycin that could be used 
against emerging resistant Gram-positive bacteria. The A40926 biosynthetic gene cluster 
(dbv), which consists of 37 genes, encodes two regulators, Dbv3 (LuxR-like) and Dbv4 
(StrR-like), as well as the response regulator (Dbv6) and the sensor-kinase (Dbv22) of a 
putative two-component system. Previous work demonstrated a positive role of Dbv4 in 
antibiotic production by activating the transcription of 13 dbv genes; up to now no role was 
assigned to Dbv3, Dbv6 and Dbv22. In addition, an IclR-like protein is thought to be 
involved in dbv4 expression. The iclR gene is not localized in the dbv cluster and encodes a 
putative DNA binding protein that controls growth, primary and secondary metabolism in 
other bacteria. 
Mutants in dbv3, dbv4, dbv6, dbv22 and iclR genes were independently generated, 
revealing that Dbv3, Dbv4 and IclR are necessary for antibiotic production, while the 
response regulator Dbv6 and the sensor-kinase Dbv22 do not seem to influence A40926 
production. 
 
Phenotypic analysis of the dbv6 and dbv22 mutants revealed that Dbv6 (VanR like) and 
Dbv22 (VanS like) do not influence bacterial growth, but they could control resistance; 
indeed, the mutants are more sensitive to vancomycin (a commercially available 
glycopeptide) in respect to the wild type.  
 
Dbv3 belongs to the LAL family (Large ATP-binding regulators of the LuxR family). The 
LuxR transcriptional regulator is a key player of a large variety of quorum sensing 
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processes, regulating the expression of genes related to antibiotic biosynthesis, motility, 
nodulation, plasmid transfer, bioluminescence, pathogenicity, biofilm formation, etc. 
Kinetic growth curves of dbv3 mutant (Ko dbv3) revealed that Dbv3 does not influence 
bacterial growth in liquid rich medium (R3) but that it is necessary for antibiotic 
production. Semi-quantitative RT-PCR analysis after 48 hours of growth demonstrated that 
Dbv3 controls some genes involved in the antibiotic production. To further investigate the 
role of Dbv3 in differentiation and growth, strains that over-express dbv3 were generated. 
Phenotypic analyses revealed no differences in growth on R3 medium, while antibiotic 
production was about two fold more abundant than in the wild type. 
 
In experiments of affinity chromatography using as bait a DNA fragment upstream of the 
gene dbv4 (called P4) a protein IclR-like was isolated, that could have a role in regulating 
the expression of dbv4 gene. 
IclR family comprises regulators acting as repressors, activators and proteins with a dual 
role (activator and repressor). Members of the IclR family control genes whose products 
are involved in the glyoxylate shunt, multidrug resistance, degradation of aromatics, 
inactivation of quorum-sensing signals, determinants of plant pathogenicity, antibiotic 
production and sporulation. 
Since P4 is localized downstream dbv4 transcriptional start site, mapped by S1-mapping 
experiments, a negative role to IclR was hypothesized. Indeed, qRT-PCR analysis showed 
that the levels of transcription of genes iclR and dbv4 have an opposite trend: iclR is more 
transcribed when a low yield of antibiotic is produced; dbv4, vice versa, is more 
transcribed when antibiotic production is high. These preliminary data suggest a possible 
involvement of IclR in A40926 production.  
Three knock out iclR mutants were generated. Morphological and physiological analysis 
revealed that they lost the capacity to grow on minimal medium, they were not pigmented 
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in the rich medium R3-agar and produced the antibiotic after 9 days of growth, while wild 
type produced after 3 days in the same growth condition. Different carbon sources and 
aminoacids were added to minimal medium to restore growth and pigmentation and to 
understand which metabolic pathways was under IclR control. At the same time, 
morphological and physiological analysis of five iclR over-expression mutants revealed 
that IclR has a negative effect on antibiotic production confirming its involvement in 
A40926 biosynthesis. 
To investigate whether IclR directly regulates antibiotic biosynthesis, an His-tagged IclR 
was overproduced in Escherichia coli and purified. Gel mobility shift assays of different 
kind of DNA probe were carried out using the purified His6-tagged IclR. No bindings were 
detected. This could be due to an incorrect protein folding or to the need of some cofactors 
to help the protein to bind DNA. 
 
This study provides new insights into gene expression in gram-positive bacteria, 
specifically focusing on the complex regulatory network governing both growth and 
secondary metabolism. 
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Actinomycetes 
 
Actinomycetes are soil-dwelling Gram-positive bacteria that have an unusually complex 
life cycle, which makes them particularly interesting for the study of bacterial 
development. Moreover, they are industrially relevant as producers of a wide range of 
bioactive secondary metabolites, including many antibiotics of clinical and commercial 
importance. 
The understanding of actinomycete biology has been based on extensive studies on the 
model organism Streptomyces coelicolor over many years and on the availability of its 
complete genome sequence (Bentley et al, 2002). After spore germination, vegetative 
growth leads to formation of a mycelium consisting of a ramifying network of syncytial 
hyphae that penetrate a moist substrate by extension of hyphal tips and subapical 
branching. Subsequent reproductive growth often proceeds with the formation of 
filamentous aerial hyphae that eventually undergo differentiation into chains of 
unigenomic spores (Fig. 1) 
 
Fig. 1) Cell cycle features of Streptomyces development. Mycelial structures (MI, first 
compartmentalized mycelium; MII, second early and late multinucleated mycelia), cell 
death processes, and traditional denomination (“substrate” and “aerial”) are indicated. 
Developmental time points at which samples were collected are indicated by an asterisk. 
a–d, confocal lasers canning fluorescence microscopy analysis of horizontal sections of 
cultures (Manteca et al. 2010). 
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This complex developmental cycle includes programmed cell death phenomena that make 
this bacterium a multicellular prokaryotic model. There are two differentiated mycelial 
stages: an early compartmentalized vegetative mycelium (first mycelium) and a 
multinucleated reproductive mycelium (second mycelium) arising after programmed cell 
death processes (Manteca et al. 2010). 
Morphological differentiation in actinomycetes is strictly related to physiological 
differentiation: indeed the onset of morphological differentiation generally coincides with 
the production of secondary metabolites, such as antibiotics. 
During cell death, degradative proteins are synthesized and involved in an extensive 
degradation of some cellular constituents (proteins and lipids) used for a second growth 
phase. This phenomenon accompanies antibiotic production: antibiotic could serve to 
protect nutrients released from dead cells or by other soil bacteria; antibiotic, naturally 
produced in low amounts, could act as signal molecules or hormones to coordinate the 
developmental cycle. 
If on one hand, many factors with pleiotropic activity were identified, as key players to 
control both morphological and physiological differentiation in S. coelicolor, on the other 
hand for most actinomycetes mechanisms and factors governing morphological and 
physiological processes were not deeply investigated. 
The focus of this project is the Gram positive bacterium Nonomuraea ATCC sp. 39727.  
The kind Nonomuraea, before Actinomadura or also Microtetraspora (Monciardini, 2004), 
comprising 134 different strains, one of which is Nonomuraea sp. ATCC39727, an aerobic 
actinomycete genetically and physiologically poorly characterized. 
A peculiar aspect of Nonomuraea sp. ATCC39727 is represented by morphological and 
pigmentation changes that occur during growth: on a solid rich medium (R3-Agar), 
Nonomuraea undergoes changes in morphology (it shows a “rose” shape, with notched 
colony side) and in pigmentation (from white to pink and purple), but it does not produce 
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spores (Fig. 2). Approximately after 3 days of growth, it produces the glycopeptide 
A40926 (Fig. 3). A40926 is similar to vancomycin, the antibiotic of last resort against 
multi-drug resistant pathogens. The antibiotic dalbavancin, derived by semy-synthetic 
process by A40926 and belonging to the teicoplanin family, is a semi synthetic 
lipoglycopeptide for treatment of infections by multi-resistant gram-positive bacteria, in 
phase III of clinical trials. 
 
         
Fig. 2) Morphology of Nonomuraea colonies 
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Glycopeptides 
 
The glycopeptides are a class of antibiotics with a complex chemical structure of very high 
molecular weight. Up to now about 50 glycopeptides were isolated, but only two, 
Vancomycin (produced by the strain Amycolatopsis orientalis) and Teicoplanin (produced 
by Actinoplanes teichomyceticus), are on the market and used for the treatment of 
persistent infections by Gram-positive multi - resistant pathogens. 
Chemically, this family of glycopeptide antibiotics consists of a heptapeptide core 
constituted by proteinogenic and non-proteinogenic amino acids, such as 3,5-
dihydroxyphenylglycine (DPG) and 4-hydroxyphenylglycine (HPG). The heptapeptides 
are assembled by nonribosomal peptide synthetases (NRPS) and then modified by 
oxidative cross-linking of the electron-rich aromatic side chains that make the peptide 
scaffold rigid. Further tailoring steps may include halogenation, glycosylation, 
methylation, acylation, and sulfation. 
 
A40926 was originally described as a complex of related compounds differing by the type 
of N-acyl chain attached to the glucoronic acid moiety and for the presence or absence of 
an O-linked acetyl residue at position 6 of the mannose (Goldstein et al., 1987; Waltho et 
al., 1987), giving rise to compounds 1 and 2, respectively (Fig. 3). Recently, it was 
demonstrated that dbv23 gene is responsible for adding the acetyl group to the mannose 
moiety and that compound 1 is most likely the end product of the pathway (Sosio et al., 
2010).  
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Fig.3 Structure of A40926. 
 
The Gram-negative bacteria are naturally resistant to lycopeptides for the inability of these 
molecules, rather voluminous, to cross the external lipid membrane. 
The bacterial cell wall of Gram-positive bacteria is characterized by a thick layer of 
peptidoglycan (Fig. 4): it is a crystal lattice structure formed from linear chains of two 
alternating amino sugars, namely N-acetylglucosamine (GlcNAc or NAG) and N-
acetylmuramic acid (MurNAc or NAM). The alternating sugars are connected by a β-(1,4)-
glycosidic bond. Each MurNAc is attached to a short (4- to 5-residue) amino acid chain, 
containing L-alanine, D-glutamine, L-lysine, and one or two D-alanine with a 5-glycine 
interbridge between tetrapeptides. The D- amino acids in the third position are essential for 
the cross-linking of the peptidoglycan chain. The peptide cross-link is formed by a 
transpeptidase between the free amine of the D-amino acid in the third position of a 
peptide chain and the D-alanine in the fourth position of another chain. The precursor form 
of the peptide has an extra D-alanine, which is released during the cross-linking step. 
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Fig 4) Chemical structure of peptidoglycan. 
 
Glycopeptides inhibit the synthesis of cell wall in susceptible microbes by inhibiting 
peptidoglycan synthesis. The glycopeptides act by complexing the dimer D-Ala-D-Ala 
basal unit of the peptidoglycan through the formation of five hydrogen bonds. This 
interaction prevents transglycosylation and transpeptidation reactions, required for the 
insertion of the units in the basal area of growth of the peptidoglycan, resulting in cell lysis 
and death of the bacterium sensitive to glycopeptides. 
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A40926 biosynthesis 
 
The dbv gene cluster for the biosynthesis of A40926 includes 37 open reading frames 
participating in antibiotic biosynthesis, regulation, resistance, and export (Fig. 5).  
Putative roles were assigned by sequence analysis to most of the 37 dbv ORFs (Sosio et al., 
2003). 
 
Fig 5) dbv cluster in Nonomuraea 
 
Formation of the A40926 heptapeptide skeleton requires the specialized synthesis of three 
amino acids: hydroxyphenylglycine (HPG), dihydroxyphenylglycine (DPG), and β-
hydroxytyrosine (βHT). dbv1 and dbv2 show considerable sequence identity to Hmo and p-
hydroxymandelate synthetase (HmaS), respectively, which are required to convert p-
hydroxyphenylpyruvate into p-hydroxyphenylglyoxylate during HPG synthesis in 
vancomycin biosynthesis (Hubbard et al., 2000; Li et al., 2001). dbv31 to dbv34 are 
closely related to DpgA through DpgD, respectively required for DPG formation (Chen et 
al., 2001; Pfeifer et al., 2001). dbv37 encodes a homolog of HpgT, the amino transferase 
required for the transamination of both p-hydroxyphenylglyoxylate and 3,5-
dihydroxyphenyl-glyoxylate, to yield HPG and DPG, respectively. dbv5, which encodes a 
homolog of prephenate dehydrogenase, may also participate in HPG synthesis (Hubbard et 
al., 2000; Pfeifer et al., 2001). 
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Synthesis of the A40926 heptapeptide precursor is catalyzed by a nonribosomal peptide 
synthetase (NRPS, Fig. 6). 
 
 
 
Fig. 6) General scheme of NRPS. Each NRPS module incorporates one amino acid into 
the growing peptide chain. The modules are composed of several domains: Adenylation 
domain (A) is responsible for substrate selectivity, peptidyl carrier protein domain (T) and 
condensation domain (C) work synergistically to form the peptide bond, and thioester 
domain (TE) which terminates the reaction, resulting in either a linear or cyclic 
polypeptide (Donadio et al., 2007) 
 
In NRPSs, each elongating module is characterized by the presence of at least three 
domains: an adenylation domain responsible for substrate recognition and activation, a 
thiolation domain, which covalently binds amino acids and elongating peptides as 
thioesters; and a condensation domain, which catalyzes peptide bond formation. The 
initiation module does not usually contain a condensation domain. In addition to these core 
domains, an epimerization domain is usually present in those modules that convert an L 
amino acid into the D form. The last module is usually completed by a thioesterase 
domain, which hydrolyzes the thioester bond linking the completed peptide to the NRPS 
(Marahiel, 1997). The dbv16, dbv17, dbv25, and dbv26 encode the 7-module NRPS 
required for A40926 formation. dbv15 encodes a short, highly conserved peptide of 
unknown function, specified by many actinomycete clusters containing NRPS genes. 
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dbv36 encodes a type II thioesterase that could hydrolyze misprimed or misacylated 
thiolation domains. 
The A40926 aryl groups are joined by three ether links and one C-C link carried out by 
P450 monooxygenases encoded by three separate oxy genes. dbv11, 12, and 14, which are 
best related to OxyC, OxyB, and OxyA, respectively, are involved in cross-linking of 
amino acids 5–7, 4–6, and 2–4. By exclusion, dbv13 should be involved in cross-linking of 
amino acids 1–3. 
One chlorine atom is present on one residue each of βHT and DPG in A40926. A single 
halogenase gene, specified by dbv10, is present in the dbv cluster (Bischoff et al., 2001). 
Interestingly, the presence of chlorine atoms appears to enhance antibacterial activity in 
some glycopeptides (Nagarajan, 1993). The following modifications are expected to occur 
on the newly formed A40926 aglycone: N-methylation of the terminal HPG residue, 
addition of a glucosamine moiety to the hydroxyl group of amino acid 4, N-acylation of the 
glucosamine residue, oxidation of the primary alcohol of the glucosamine moiety to yield a 
carboxyl group, and addition of a mannose residue to the hydroxyl group of amino acid 7. 
Five proteins, encoded by dbv9, 20, 23, 27, and 29, are likely to be involved in these 
tailoring steps. dbv9 is a glycosyltransferase, which glycosylates amino acid 4 (Solenberg 
et al., 1997; Losey et al., 2001). dbv27 is likely to catalyze N-methylation of the terminal 
HPG residue (O’Brien et al., 2000). dbv23 encodes a protein highly related to members of 
the acyltransferase 3 family, so it might participate in N-acylation. dbv20 is responsible of 
A40926 mannosylation. dbv29 contains motifs typical of FAD binding and shows 
considerable matches to other proteins described as hexose oxidases. This gene is likely to 
govern oxidation of the glucosamine moiety to yield the corresponding acid. In addition, 
the presence of a putative signal sequence at the N terminus suggests that the product of 
dbv29 is secreted, and hence that oxidation occurs outside the cytoplasm.  
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dbv7 contains motifs typical of the VanY-family of carboxypeptidases, that are enzymes 
involved in the extracytoplasmic removal of the terminal alanine residue from nascent 
peptidoglycan, reducing the extent of glycopeptide binding to its molecular target. dbv7, 
thus, is involved in conferring some level of A40926 resistance to the producing strain 
(Binda et al., 2012; Binda et al.,2013). 
Four dbv genes are likely to encode export functions: dbv24, dbv35, dbv18 and dbv19.  
Finally, the cluster encodes the regulators Dbv3 (LuxR-like) and Dbv4 (StrR-like), as well 
as the response regulator Dbv6 and the sensor-kinase Dbv22, that may be part of a two-
component system. 
 
Dalbavancin is synthesized from A-40926 in a three-step procedure. An important step in 
the synthesis of dalbavancin is the amidation of the peptide carboxyl group, resulting in 
improved potency of dalbavancin against staphylococci. The removal of the 
acetylglucosamine group was an intentional effort to improve the activity of dalbavancin. 
Additionally, dalbavancin has an acylaminoglucuronate instead of an acylglucosamine on 
ring. The long lipophilic side chain serves a dual purpose by both extending the halflife, 
which allows for once-weekly dosing, as well as anchoring the compound to the 
membrane, which enhances its antimicrobial activity by improving its affinity for the 
terminal D-Ala-D-Ala. 
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Regulation and Regulators of A40926 production 
 
 Stringent response 
In several microorganisms, such as Nocardia species (Ishikawa et al., 2006), the 
production of antibiotics and other secondary metabolites occurs following the restriction 
of specific nutrients, such as nitrogen compounds and phosphate. The lack of specific 
nutrients is perceived by microorganisms through complex signaling mechanisms (Fig. 7). 
The study of these pathways is often the key to the understanding of regulatory processes 
underlying the synthesis of secondary metabolites.  
 
 
Fig. 7) Diagram of the bacterial stringent response system. Two parallel pathways 
synthesize pppGpp (which is subsequently converted into ppGpp) from ATP and GTP in 
response to any of several stress signals. Through interactions with RNA polymerase 
(RNAP), ppGpp alters much of metabolism. - indicates inhibition; + indicates stimulation 
(Magnusson et al, 2005) 
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In some bacteria of the phylum Actinobacteria, such as Streptomyces lividans and 
Streptomyces coelicolor, a shortage of nitrogen compounds is reflected in the increased 
concentration of tRNA discharges, a consequence of the limited availability of amino 
acids; this phenomenon leads to the activation of Rel A protein that binds ribosome stalling 
and allows the synthesis of the nucleotide ppGpp (guanine 5'- diphosphate 3'- diphosphate , 
or GDP- 3'difosphate). In conditions of nutrient deficiency, the ppGpp is accumulated and 
binds to the RNA polymerase subunit (encoded by the rpoB gene), directing the 
transcription of genes important for the production of secondary metabolites. This 
mechanism of adaptation to changes in environmental conditions is called "stringent 
response" (Donadio et al., 2008; Talà et al., 2009). 
 
 Merodiploidy of rpoB  in Nonomuraea 
Several actinomycetes possess two rpoB genes (e.i. Nocardia species), in contrast to the 
widely accepted consensus of the existence of a single RNA Polimerase (RNAP) in 
bacteria. In Nonomuraea sp. strain ATCC 39727, rpoB
(S)
 and rpoB
(R)
 provide the 
microorganism with two functionally distinct and developmentally regulated RNAPs 
(Vigliotta et al., 2004; Talà et al., 2009). rpoB
(R)
 is characterized by an 18-bp in-frame 
deletion and mutations causing five amino acid substitutions (H426N, S431N, F445M, 
S474Y, and M581D), located within or close to the so-called rif cluster that play a key role 
in fundamental activities of RNAP. rpoB
(R)
 transcription is tightly regulated during 
Nonomuraea growth. Indeed, transcriptional analysis demonstrated that expression of the 
rpoB
R
 allele is growth phase-dependent in the wild type strain: the allele was silent during 
the pseudo-exponential phase of growth and began to be expressed during the transition to 
the stationary phase. Moreover, the constitutive expression of rpoB
(R)
 gene increased the 
production of the glycopeptide antibiotic A40926 in this organism.  
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The merodiploidy might contribute to the developmental strategy of this actinomycete. 
rpoB
(R)
 and rpoB
(S)
 gene products may contribute to assemble growth phase-specific 
variants of RNA polymerase with different functional properties 
 
 RNA decay 
Polynucleotide phosphorylase (PNPase) has been extensively studied in Streptomyces. It 
catalyses the 3′–5′ phosphorolysis of RNAs and can also produce ribopolymers, using 
nucleoside diphosphates as substrates. Because of this latter activity, PNPase provides 
RNAs with 3′-tails that contain significant levels of G, C and U in addition to A residues 
that facilitate RNA degradation (Bralley and Jones, 2002). In contrast, in other bacteria 
including Escherichia coli, the major enzyme responsible for 3′-tailing of RNA is a 
poly(A) polymerase (Cao and Sarkar, 1992), an enzyme that is absent in streptomycetes. In 
these latter bacteria PNPase might be the unique RNA 3′-polynucleotide polymerase 
(Bralley and Jones, 2003). Evidence is provided that ppGpp acts as a negative modulator of 
the Nonomuraea sp. PNPase activity during the transition into the stationary phase thereby 
representing a novel link between (p)ppGpp, secondary metabolism and mRNA turnover. 
So (p)ppGpp may exert a modulatory effect on gene expression at the level of RNA decay 
also. In E. coli, a fast-growing microorganism with a poor secondary metabolism arsenal, 
ATP slows down phosphorolytic mRNA decay at high-energy charge (Del Favero et al., 
2008) while ppGpp accelerates PNPase activity, presumably during the stationary phase. In 
Nonomuraea, a slow-growing microorganism with a rich arsenal of secondary metabolites, 
ppGpp slows down mRNA decay during the stationary phase, when production of 
secondary metabolites maximally occurs. Thus, different regulatory patterns may reflect 
different life styles (Siculella et al., 2010). 
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 Phosphate control 
Apart from carbon, nitrogen and oxygen, phosphorus is the most important nutrient for 
living cells and since the concentration of free phosphate is usually low in natural 
environments, such as soil and water, free-living bacteria have developed physiological 
mechanisms for coping with phosphate starvation. In Streptomyces coelicolor phosphate 
controls antibiotic biosynthesis by the two-component PhoR-PhoP system (Fig. 8). The 
PhoR protein is a membrane sensor kinase, whereas PhoP is a member of the DNA-
binding response regulators (OmpR family). PhoP activates transcription of AfsS that 
positively regulates secondary metabolism biosynthesis through the transcription of 
pathway-specific activators, like actII-ORF4 and redD for actinorodin and 
undecilprodigiosin biosynthesis, respectively (Martín, 2004). 
 
 
 
Fig.8) Proposed cascade mechanism involved in phosphate control of actinorodin and 
undecilprodigiosin biosynthesis in S. coelicolor (Martin, 2004) 
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Also in Nonomuraea A40926 production is negatively influenced by phosphate (Fig. 9). 
A40926 production started after 35 hours of growth in two defined media with initial 
phosphate concentrations of 2 mM and 4.2 mM. After 47 hours the A40964 yield was 
different in the two phosphate conditions: A40926 was produced in higher amount in 
LowP condition in respect to HighP condition. In particular, phosphate depletion induced 
dbv4 transcription. 
 
 
 
Fig.9) A40926 production in batch fermentation in Nonomuraea. Growth (squares), 
phosphate concentration (circles), and A40926 production (triangles) were monitored with 
initial phosphate concentrations of 2 mM (LowP; closed symbols) and 4.2 mM (HighP; 
open symbols) Alduina et al, 2007. 
 
 
 Glucose metabolism 
Actinomycete bacteria generally metabolize glucose via the Embden–Meyerhof–Parnas 
(EMP) and pentose-phosphate (PP) pathways (Bai et al., 1975; Salas et al., 1984; Dekleva 
and Strohl, 1988; Marx et al., 1996; Obanye et al., 1996). Nonomuraea metabolizes 
glucose mainly through the Entner–Doudoroff (ED) pathway (Fig.10), while the EMP and 
PP pathways are less active.  
The ED pathway was discovered in Pseudomonas saccharophila in 1952 (Entner and 
Doudoroff, 1952) and was originally considered to be utilized only by a limited number of 
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Gram negative bacteria. However, the pathway has since been identified in a wide range of 
organisms within the archaea, bacteria, and eukarya (reviewed in Conway, 1992) and is 
evidently widespread in nature. The Entner–Doudoroff pathway also has a net yield of 1 
ATP for every glucose molecule processed, as well as 1 NADH and 1 NADPH. By 
comparison, glycolysis has a net yield of 2 ATP and 2 NADH for each processed glucose. 
The ED pathway is thought to evolutionarily predate the more energetically favorable 
Embden–Meyerhof–Parnas (EMP) pathway (Mele´ndez – Hevia, et al., 1997; Romano and 
Conway, 1996). In some organisms, e.g., Zymomonas mobilis and most Pseudomonas 
species, the ED pathway is the only means of metabolizing glucose. In other cases the 
pathway plays a peripheral role in the central carbon metabolism, e.g., in Escherichia coli, 
where it is used for metabolism of gluconate and is induced only in the presence of this 
carbon source. In the actinomycete Mycobacterium smegmatis the contribution of the ED 
pathway was marginal in relation to the activities of the EMP and PP pathways (Bai et al., 
1976). 
 
Fig. 10) Entner–Doudoroff (ED) pathway. Zwf, glucose-6-phosphate dehydrogenase; 
DevB, 6-phosphogluconolactonase; Edd, 6-phosphogluconate dehydratase; Eda, 2-keto-3-
deoxy-6-phosphogluconate aldolase; KDPG, 2-keto-3-deoxy-6-phosphogluconate 
 
In Nonomuraea a marked metabolic shift through the EMP pathway at the expense of the 
flux through the ED pathway was observed, shortly after phosphate depletion and in 
connection with the increase in A40926 antibiotic productivity. 
22 
 
It is therefore likely that regulation of the EMP and ED pathway activities takes place on 
the level of the enzymes, e.g., by phosphate inhibition or by the supply of PPi for the 
phosphofructokinase. 
 
 Cis acting regions and regulatory genes 
Sequence information is also available for five other gene clusters devoted to 
glycopeptides, namely, chloroeremomycin (cep), balhimycin (bal), complestatin (com), 
A47934 (sta), and teicoplanin (tcp) (Donadio et al., 2005).  
Four conserved stretches of non-coding DNA were identified and, interestingly, three of 
them are associated with segments of conserved synteny.  
A 115-bp segment immediately preceding the dpgA start codon shows significant 
conservation in all five clusters (indicated as the yellow dot “a” in Fig.11). The five 
clusters also present a conserved 80-bp segment immediately preceding the start codon of 
the gene encoding the ABC transporter (indicated as the green dot “b” in Fig.11). 
Upstream of oxyA, a 111-bp segment is conserved in all five clusters (indicated as the light 
blue dot “c” in Fig.11). A highly conserved 64-nt segment is present in all clusters except 
dbv (indicated as the orange dot “d” in Fig .11).  
Some of these conserved intergenic regions may represent binding sites for transcriptional 
regulators (e.g. the StrR-like regulator encoded in all clusters). Others might have been 
involved in the mobilization of gene cassettes. In any case, their existence in otherwise 
divergent clusters suggests important role(s) for these conserved elements. 
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Fig. 11) Comparative analysis of balhimycin (bal), chloroeremomycin (cep), 
complestatin (com), A40926 (dbv), A47934 (sta), and teicoplanin (tcp) glycopeptides 
gene clusters. The genes present in each cluster are indicated by arrows drawn to scale, 
except in the case of the NRPS genes (thick arrows), which are drawn on a reduced scale. 
The segments of conserved synteny are identified by the color coding, and labeled with 
capital letters designating gene names: yellow, dpgABCD; light blue, oxy-hal region; pink, 
gtf region. Other colors indicate: red, hmaS-hmo; dark green, genes encoding the ABC 
transporter and NRPS modules 1 and 2; bright green, genes encoding NRPS modules 4–7 
and the MbtH-like polypeptide; light brown, strR-like; dark brown, hpgT and the 
prephenate dehydrogenase-encoding gene; dark blue, the membrane ion antiporter gene. 
The black arrows denote genes shared by at least two clusters; while gray arrows refer to 
unique genes. Conserved IGSs (lower case letters) are symbolized by colored dots, as 
follows: yellow, dark green, light blue and orange indicate the conserved IGSs. (Donadio 
et al., 2005). 
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All clusters contain an strR-like regulator gene (Table 1). StrR is a well-studied pathway-
specific transcriptional regulator that activates the expression of streptomycin biosynthetic 
genes in Streptomyces griseus and Streptomyces glaucescens. 
 
 
 
Table 1) Distribution of the regulator genes among the five glycopeptide clusters. 
 
 
The phosphate-controlled regulator Dbv4 (StrR-like protein) is a cluster specific positive 
regulator and governs two key steps in A40926 biosynthesis: the biosynthesis of the non-
proteinogenic amino acid 3,5-dihydroxyphenylglycine and critical tailoring reactions on 
the heptapeptide backbone (Alduina et al., 2007). 
In particular, Dbv4 is a DNA-binding protein which acts as a regulator of A40926 
biosynthesis by binding to the region upstream of dbv14 and dbv30 and likely controlling 
expression of two operons of the dbv cluster: the dbv14-dbv8 operon, encoding the four 
cross-linking oxygenases, the halogenase, the N-acetylglucosamine transferase and the N-
acylase, and the dbv30-dbv35 operon, encoding the four enzymes involved in DPG 
biosynthesis, the sodium proton antiporter and a protein of unknown function. 
Dbv4 was clearly unable to bind to its own upstream region. Similarly, the StrR-like 
regulator is not expected to control its own expression in the tcp clusters. 
Furthermore, in experiments of affinity chromatography using as bait a DNA fragment 
upstream of the gene dbv4 (called P4), a protein IclR-like was identified, that could have a 
role in regulating the expression of dbv4 gene. 
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The dbv3 genes (coding for a LuxR-like protein), dbv6 (which encodes a putative response 
regulator, similar to VanR) and dbv22 (which encodes a putative sensor regulator, similar 
to VanS) are localized in dbv gene cluster. Instead, the position of the iclR gene in 
Nonomuraea genome is not known. 
Since poorly characterized in actinomycetes, the study of Dbv3, Dbv6, Dbv22 and IclR 
protein function could be especially interesting for understanding the mechanisms that 
govern metabolism and the morphological and physiological differentiation. 
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Dbv3: a Lux-R like protein 
 
Among the clusters for the five glycopeptides, only A40926 and teicoplanin gene clusters 
contain a luxR-like gene (Table 1). Dbv3 belongs to LAL family (Large ATP-binding 
regulators of the LuxR family). The LuxR transcriptional regulator is a key player of a 
large variety of Quorum Sensing processes in many bacteria, regulating the expression of 
genes related to many processes such as antibiotic biosynthesis, motility, nodulation, 
plasmid transfer, bioluminescence, pathogenicity, biofilm formation.  
The first example of LuxR protein was described in the marine bacteria Vibrio fischeri, 
where this protein is involved in a mechanism termed quorum sensing (Engebrecht et al., 
1983; Fuqua and Greenberg, 2002; Yang et al., 2009). Quorum sensing is the process by 
which bacteria communicate with one another using chemical signal molecules; a large 
group of cells can synchronize its activity responding to hormone-like molecules, acting as 
a multi-cellular organism. Bacteria can secrete signal molecules called autoinducers (AIs), 
that allow to monitor their own population density. 
Vibrio fischeri lives in symbiotic association with a number of eukaryotic hosts that 
developed a specialized light organ that is inhabited by a pure culture of a specific strain of 
V. fischeri at very high cell density (Fig. 12). In these symbiotic associations the eukaryotic 
host supplies V. fischeri with a nutrient-rich environment in which to live. The role of V. 
fischeri is to provide the host with light used as anti-predation strategy (illumination 
enables the squid to avoid casting a shadow beneath it on bright clear nights when the light 
from the moon and stars penetrates the seawater) or the luminescent regions on the fish are 
apparently seductive to fish of the opposite sex. 
When these bacteria are cultured in broth, they exhibit a lag in luminescence gene (lux) 
expression during early and mid-exponential growth, followed by a rapid increase in 
expression during the late exponential and early stationary growth phases. At low cell 
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density, LuxI produces AI (3oxo-C6- homoserine lactone) that is not accumulated in the 
environment. At high cell density, when AI concentration reaches a threshold 
concentration, it enter into cells and forms an active complex with LuxR; this complex 
binds to specific promoter sequences called lux-boxes controlling the transcription of lux 
operon. 
 
 
Fig.12) The V. fischeri luminescence genes are organized in two divergently transcribed 
units with an intergenic region of about 250 bp. One unit contains luxR, which encodes the 
250-amino-acid LuxR transcriptional activator. The other unit is a 7 genes-operon, 
luxICDABEG: luxI encodes a protein that synthesizes the autoinducer (3oxo-C6- 
homoserine lactone); the other genes play mechanistic roles in light production. 
 
The production of antibiotics in some Streptomyces spp. depends upon diffusible 
butyrolactones structurally similar to homoserine lactones. The most intensively studied is 
the A factor; it is gradually produced by AfsA and accumulated in a growth dependent 
manner (Horinouchi et al., 1994). When the concentration of A-factor reaches a critical 
level at or just before the decision point, it binds an A factor-specific receptor, ArpA, 
which has bound and repressed the promoter of adpA, and dissociates ArpA from the 
promoter, thus leading to adpA transcription and translation. The transcriptional activator 
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AdpA then activates a variety of genes that are required for the biosynthesis of secondary 
metabolites, including streptomycin, and morphological differentiation in Streptomyces 
griseus (Fig.13). 
In general, butyrolactone-mediated regulation appears similar to autoinducer-dependent 
regulation, but the two systems are actually quite distinct. While LuxR-type proteins 
activate transcription, the A-factor receptor is a repressor that is neutralized by A factor. 
 
 
 
Figure 13). The A-factor regulatory cascade in S. griseus. 
 
In the model S. coelicolor the protein ScbR2, homologue of γ-butyrolactone (GBL) 
receptor, is shown not to bind the endogenous GBL molecule SCB1; intriguingly, it could 
bind the endogenous antibiotics actinorhodin and undecylprodigiosin as ligands, leading to 
activation of a cryptic type I polyketide synthase gene cluster (Fig. 14). 
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Likewise, JadR2 is also a putative GBL receptor homologue in Streptomyces venezuelae. 
When JasR2 binds cloramphenicol and jadomycin, it derepresses jadR1: JadR1 activates 
jadomycin biosynthesis and represses chloramphenicol biosynthesis (Xu et al., 2010). 
Antibiotics are known to have a general signaling role to induce global changes in gene 
transcription in a bacterial community; moreover, like quorum sensing molecules, 
antibiotics can also act as intracellular signals to induce downstream responses thanks to 
GBL receptors. 
 
 
Fig.14) Cross coordination of different antibiotic biosynthesis by pseudo GBL 
receptors 
 
Two S. coelicolor LAL proteins were recently found to positively regulate the production 
of blue pigmented polyketide actinorhodin (Act) and globally affect various cellular 
processes, i.e. both regulators are involved in the phosphate starvation response (Guerra et 
al. 2012). 
 
 
In silico analysis shows that Dbv3 is a LuxR like protein of 867 amino acids composed by 
two domains (Fig.15). The C-terminal DNA-binding domain of Dbv3 contains a helix-
turn-helix motif. Indeed, proteins belonging to this group are response regulators; some act 
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as transcriptional activators, others as transcriptional repressors. A dimerization interface is 
present in the C-terminal domain. The Dbv3 N-terminal region contains a putative P-loop 
NTPase superfamily domain. This family of regulators is characterized by the unusual size 
of its members. The P-loop NTPase domain hydrolyses the β–γ phosphate bond of a bound 
nucleoside triphosphate (often ATP or GTP) and utilizes the free energy of NTP hydrolysis 
to induce conformational changes in other molecules.  
 
 
Fig.15) Dbv3 conserved domains 
 
 
31 
 
Dbv6 and Dbv22: a two component system 
 
Dbv6 is a protein VanR-like, while Dbv22 could be the sensor on the membrane. VanS and 
VanR are an example of a two-component system, identified in pathogenic bacteria 
resistant to the glycopeptide vancomycin (Hong, et al 2008). In S. coelicolor it has been 
shown that VanS and VanR activate the transcription of vanHAX genes, for resistance to 
the glycopeptide antibiotic vancomycin (Fig. 16). The presence of VanR / VanS in many 
microorganisms producing glycopeptides and not, led to hypothesize a broader role 
possibly associated with morphological differentiation. 
In Nonomuraea vanHAX genes are not present but it has the vanY gene, which encodes a 
carboxypeptidase able to cut the D-alanyl-D-alanine end (D-Ala D-Ala) of the 
peptidoglycan precursor outside the cell membrane. VanY is a novel protein involved in 
the mechanism of self-resistance in Nonomuraea sp. ATCC 39727. VanY (196 residues) is 
encoded by the dbv7 gene within the dbv biosynthetic cluster devoted to A40926 
production.  
 
 
Fig. 16) Mechanism of action of VanR-VanS in S. coelicolor (Hong et al., 2005) 
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The analysis of the sequence suggests the presence of a hydrophobic transmembrane 
portion and two conserved sequences (SxHxxGxAxD and ExxH) in the extracytoplasmic 
domain that are potentially involved in coordination of Zn
(2+)
 and catalytic activity. The 
presence of these conserved sequences indicates a similar mechanism of action and 
substrate binding in VanY as in VanY, VanX and VanXY Zn
(2+)
-dependent D,D-
carboxypeptidases and D-Ala-D-Ala dipeptidases acting on peptidoglycan maturation and 
involved in glycopeptide resistance in pathogens (Binda et al., 2012). A recent work 
indicated that the minimum inhibitory concentration (MIC, that is the lowest concentration 
of an antimicrobial that inhibits the visible growth of a microorganism after overnight 
incubation) of Nonomuraea sp. ATCC 39727 towards A40926 during vegetative growth 
was 4 g/ml, but this increased to ca. 20 g/ml during A40926 production (Marcone et al., 
2010). This result indicated that resistance to A40926 is regulated by A40926 production. 
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IclR 
 
Members of the IclR family are proteins of around 250 residues. These regulators have a 
helix-turn-helix DNA binding motif in the N-terminal domain and bind target promoters as 
dimers or as a dimer of dimers.  
This family comprises regulators acting as repressors, activators and proteins with a dual 
role. In E. coli IclR uses two modes of repression. The repression mode I involves IclR 
bound to its target site overlapping RNA polymerase binding site, so that occupancy of the 
site by IclR prevents the entry of the polymerase. The repression mode II involves IclR 
bound to a distal site with respect to the RNA polymerase site. The interaction of IclR with 
the α-subunit of the promoter-bound RNA polymerase destabilizes and disassociates the 
open complex (Yamamoto & Ishihama, 2003, fig. 17). IclR-type positive regulators bind 
promoter DNA in the absence of effectors. 
 
 
Fig 17) Modes of repression of IclR in E. coli (Molina-Henares et al., 2004) 
 
Members of the IclR family have pleiotropic roles (Fig.18) and control genes, whose 
products are involved in the glyoxylate shunt, multidrug resistance, degradation of 
aromatics, inactivation of quorum-sensing signals, determinants of plant pathogenicity and 
sporulation. In S. coelicor ssgR facilitates the sporulation via SsgA, factor that is involved 
in sporulation and morphogenesis (Traag et al., 2004).  
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IclR family members also control bacterial adaptation to the fluctuation of environment, 
regulating  efflux pumps to exclude toxic substances. For example, TtgV of Pseudomonas 
putida is an IclR repressor of ttgGHI operon encoding  pumps empowering bacterial higher 
resistance to toluene. IclR-like AttJ regulates stability of quorum sensing signals in 
Agrobacterium tumefaciens. 
LtbR in C. glutamicum negatively controls leuB, leuC and trpE involved in the production 
of leucine and tryptophane. 
In S.coelicolor GylR is responsible of glycerol catabolism: in fact GylR is the repressor of 
the gylCABX operon and it also acts as a negative autoregulator (Zhou et al., 2012). 
 
 
Fig.18) Pleiotropic role of IclR family among bacteria (Zhou et al., 2012) 
 
AreB in Streptomyces clavuligerus activates transcription of  leuCD operon involved in 
leucin biosynthesis (Santamarta et al., 2007). Therefore, AreB controls cephamycin C and 
clavulanic acid production and fatty acid catabolism (Fig.19,a). In S. coelicolor NdgR 
positively controls leucin biosynthesis, negatively controls actinorhodin and 
undecilprodigiosin production; it is also involved in quorum sensing mechanism (Fig.19, 
b). Deletion mutants in ndgR showed poor growth in a defined minimal medium and 
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supplementation of cysteine and methionine corrected growth, suggesting that NdgR 
induced cysteine-methionine biosynthesis (Kim et al., 2012).  
 
 
Fig.19) Role of IclR family in S. clavuligerus and S. coelicolor (Kim et al., 2012). 
 
 
Bacteria have developed sophisticated mechanisms to adapt to environmental changes. For 
example, carbon catabolite repression (CCR) allows bacteria the assimilation of a preferred 
(i.e. rapidly metabolisable) carbon source when they are exposed to more than one 
carbohydrate. CCR is a complex regulatory phenomenon frequently mediated via several 
mechanisms. This is usually achieved through inhibition of synthesis of enzymes involved 
in catabolism of carbon sources other than the preferred one. The catabolite repression was 
first shown to be initiated by glucose and therefore sometimes referred to as the glucose 
effect. 
During aerobic growth of Escherichia coli on acetate as sole source of carbon and energy, 
the organism requires the operation of the glyoxylate bypass enzymes, namely isocitrate 
lyase (ICL) and the anaplerotic enzyme malate synthase (MS) and this mechanism is under 
control of an IclR protein (Fig.20). Under these conditions, the glyoxylate bypass enzyme 
ICL is in direct competition with the Krebs cycle enzyme isocitrate dehydrogenase (ICDH) 
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for their common substrate and although ICDH has a much higher affinity for isocitrate, 
flux of carbon through ICL is assured by virtue of high intracellular level of isocitrate and 
the reversible phosphorylation/inactivation of a large fraction of ICDH.  
 
 
 
Fig.20) Schematic representation of the metabolic routes employed by E. coli for 
acetate metabolism, highlighting the direct competition between glyoxylate bypass 
enzyme and the Krebs cycle isocitrate dehydrogenase for their common substrate 
(isocitrate). Enzymes are: 1=acetate kinase; 2=phosphotransacetylase; 3=citrate synthase; 
4=aconitase; 5=isocitrate dehydrogenase; 6=αchetoglutarate dehydrogenase; 7=isocitrate 
lyase; 8=malate synthase; 9=phosphoenolpyruvate carboxykinase; 10=pyruvate kinase; 
11=enolase; 12=malic enzyme; 13=pyruvate dehydrogenase. 
 
 
Reversible inactivation is due to reversible phosphorylation catalysed by ICDH 
kinase/phosphatase, which harbors both catalytic activities on the same polypeptide. The 
structural gene encoding ICDH kinase/phosphatase (aceK) together with those encoding 
ICL (aceA) and MS (aceB) form an operon (aceBAK; otherwise known as the ace operon) 
whose expression is intricately regulated at the transcriptional level by several regulators, i. 
e. IclR, FadR, FruR and IHF. Conversely, when bacteria are cultured on carbon sources, 
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such as glucose or glycerol, which do not employ the glyoxylate bypass as an anaplerotic 
sequence, IDH is not phosphorylated and remains fully active. The ace operon is subjected 
to repression at the transcriptional level by IclR (Cozzone et al., 2005). 
The IclR binding site of aceBAK is AAAATGGAAATTGTTTTTG, while for iclR self-
regulation is AAAATGAAAATGATTTCCA (Zhou et al. 2012). In E. coli, IclR repressor 
shows that, among various molecules (Acetate, acetyl-CoA, pyruvate, phosphoenol 
pyruvate and oxaloacetate), only phosphoenol pyruvate appeared to prevent the formation 
of the IclR-DNA complex (Cortay et al.1991). 
 
In S. coelicolor the gyl operon for glycerol catabolism is a polycistronic transcript contains 
four genes collectively termed gylCABX. The first three genes encode a putative glycerol 
transporter, a glycerol kinase, and a glycerol-3-phosphate dehydrogenase, while gylX 
encodes a gene of unknown function (Smith et al., 1988). The gyl operon is transcribed 
from two closely spaced glycerol-inducible and glucose-repressible promoters, named 
gylP1/P2. Glycerol induction and glucose repression of gylP1/P2 are probably mediated by 
the glycerol-inducible repressor GylR (an IclR like protein), whose encoding gene locates 
immediately upstream of the gylCABX operon. GylR controls the expression of both gylR 
and gylCABX (Hindle et al., 1994). Null mutations into the chromosomal gylR gene 
demonstrated that GylR is the repressor of the gylCABX operon and also revealed that 
GylR functions as a negative autoregulator. Substrate induction and catabolite repression 
of gyl are mediated through the GylR protein. This is the first direct evidence that 
catabolite repression in Streptomyces is not exerted at the transcriptional level by a general 
'catabolite repressor protein'. 
 
In the vast majority of documented cases, the preferred carbon source is glucose with the 
famous Escherichia coli glucose/lactose classical example (Inada et al., 1996). On the 
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contrary, the lactic acid bacterium Streptococcus thermophilus prefers lactose over glucose 
(van Den Bogaard et al., 2000), indicating that adaptation to special ecological niches may 
result in the choice of practically any carbohydrate as favored substrate. 
 
To my knowledge, the preferred carbon sources and the carbon catabolite repression 
mechanisms have not yet been studied in Nonomuraea. 
Moreover, up to now no role was assigned to IclR in Nonomuraea. 
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Aim of the project 
 
Actinomycetes are producers of a wide variety of bioactive secondary metabolites but 
wild-type bacteria often produce desired metabolites at low yield; thus, high production 
strains are always needed for commercial use. Classical strain improvement methods 
depend on iterative rounds of random mutagenesis on parental strain with subsequent 
large-scale screening of mutants to identify high-producing strains. Although the strategy 
was successfully applied in the fermentation industry for a long time, it is labor intensive, 
and the improved could not be easily understood. The establishment of genetic engineering 
technology for actinomycetes makes rational strain improvement possible (Chater, 1990). 
Over-expression of positive regulatory genes or disruption of negative regulatory genes 
were commonly adopted as the first step to verify the function of regulatory genes and to 
generate overproduction strains. 
My research aimed to broaden understanding the mechanisms of regulation of 
physiological differentiation and gene expression in Actinomycetes.  
In particular, the purpose of this research was to study the role of dbv3, dbv4, dbv6, dbv22 
and iclR genes and their involvement in morphological and physiological differentiation in 
Nonomuraea.  
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Construction of Nonomuraea mutants deleted in dbv3, dbv4, dbv6 and dbv22 genes 
 
To investigate the role of regulatory genes of A40926 production, Ko dbv3, Ko dbv4, Ko 
dbv6 and Ko dbv22 strains were constructed by replacing the wild-type gene with an in 
vitro generated allele interrupted by insertion of apramycin resistance cassette (Redirect 
technology). Double-crossover mutants were screened by apramycin resistance. The 
putative mutants were analyzed by PCR. For Ko dbv4, a PCR product of 1,8 Kb was 
obtained for the clone 4.9, 4.10 and clone 4.11 among the putative eleven exconjugants, 
while wild type gave a PCR product of 1,3 kp (lane 4.1-4.7 and 4.12; Fig. 21). 
 
Fig 21) PCR of putative Ko dbv4 mutants. PCR product of the mutant is indicated by a 
circle. C: positive control. 
 
 
For Ko dbv3, a PCR products of 1,8 kb was obtained for a clone (lane 4) among four 
putative exconjugants, while wild type gave a PCR product of 2,8 kb (lane 6, Fig. 22). 
 
Fig. 22) PCR of putative Ko dbv3 mutants. PCR product of the mutant is indicated by a 
circle. lane 6: positive control. 
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For Ko dbv6, a PCR products of 1,5 Kb was obtained for a clone (lane 9) among seven 
putative exconjugants, while wild type gave a PCR product of 8oo bp (lane 10, Fig. 23). 
 
Fig. 23) PCR of putative Ko dbv6 mutants. The PCR product is indicated by a circle. 
lane 10: positive control. 
 
 
For Ko dbv22, a PCR products of 1,7 kb was obtained for a clone (lane 2) among ten 
putative exconjugants, while wild type gave a PCR product of 1,5 Kb (lane 1, lane 3-12. 
Fig. 24). 
 
Fig. 24) PCR Ko dbv22 mutants. The PCR product is indicated by a circle. Lane 1: 
positive control. 
 
 
Sequencing of PCR products demonstrated that the apramycin-resistant cassette was 
correctly inserted in the target genes through homologous double-cross recombination. 
 
 
43 
 
Role of dbv3, dbv4, dbv6 and dbv22 on A40926 biosynthesis 
 
Disruption of dbv3, dbv4, dbv6 and dbv22 genes did not significantly alter growth kinetics. 
In fact, the mutants showed the same growth rate and morphological characteristics as the 
parental strain on several media (i.e. R3, MS, V01 solid media, or R3 liquid medium) 
indicating that the dbv3, dbv4, dbv6 and dbv22 genes are not critical for bacterial growth 
and differentiation.  
Interestingly, microbiological assays showed that Ko dbv3 and Ko dbv4 mutants lost the 
capacity to produce antibiotic while, wild type produced A40926 from 72 hours of growth. 
HPLC assays confirmed that no A40926 was produced by the two mutant strains. These 
results showed that Dbv3 and Dbv4 positively control A40926 biosynthesis and they are 
necessary for antibiotic production.  
Instead, dbv6 and dbv22 are not involved in A40926 biosynthesis; in fact in dbv6 and 
dbv22 mutants antibiotic production was not affected in the rich R3 broth. 
 
------------------------------------------------------------------------------------------------------------- 
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Dbv6 and resistance to A40926 
 
To evaluate a possible relationship between VanS / VanR like system and resistance to the 
antibiotic, resistance assays have been conducted. Nonomuraea wild type and Ko dbv6 
mutant were grown in SM liquid medium for 48 hours, at which time it was ascertained the 
presence of an exponential phase of growth and lack of antibiotic production. Ko dbv3 
mutant was used as control strain. Each strain was seed on SM plate in order to obtain 
confluent culture. Sterile absorbent paper disks were soaked with various concentrations of 
the glycopeptide antibiotic vancomycin (25 , 12.5 , 5 and 3.5 µg), which is similar in 
structure and mechanism of action to A40926 (which is not available as pure powder). For 
each plate four paper disks well spaced were arranged. After 72 h of growth at 30°C, we 
observed that in presence of 25 µg of vancomycin the three strains are equally sensitive, 
while at 12.5, 5 and 3.5 µg both wild-type and Ko dbv3 mutant are more resistant than 
Kodbv6 mutant, for which the zone of inhibition was larger (Fig. 25). 
  
 
Fig 25) Resistance assays to vancomycin of Ko dbv3, Ko dbv6 and wild type.  
Concentration of vancomycin 1) 3.5 µg, 2) 12.5 µgl; 3) 5 µg, 4) 25 µg. 
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To confirm this result, an other resistance assay on plate was carried out, to measure the 
minimum inhibitory concentration (MIC) of antibiotic for the bacterium (Fig.26). In each 
SM plate the following amount of Vancomycin was added: 0 - 0,5 - 1,25 - 2,5 – 5 - 12,5 - 
25 μg/ml respectively and subsequently, a dense bacterial suspension was seed on the 
plates. After 72 hours at 30° C, the Ko dbv6 strain did not grow starting from 1.25 mg / ml 
of vancomycin (MIC), while some colonies of wild-type grew in presence of  12.5 mg / ml 
of vancomycin. 
 
Fig 26) Resistance assays to vancomycin of  Ko dbv6 and wild type. Concentration of 
vancomycin 1) 0 mg /ml; 2) 0.5 mg /ml, 3) 1.25 mg / ml, 4) 2.5 mg / ml, 5) 5 mg / ml, 6) 
12.5 mg / ml; 7) 25 mg / ml. 
 
Both results suggest that Dbv6 could be positively involved in the regulation of resistance 
to glycopeptides. Further analysis are necessary to confirm these hypothesis. 
 
------------------------------------------------------------------------------------------------------------- 
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Dbv3 and Dbv4: Transcriptional control of A40926 production 
 
Dbv4 was previously shown to bind the upstream region of dbv14 and dbv30 genes and to 
control expression of the dbv14-dbv8 and dbv30-dbv35 operons (Alduina et al., 2007). 
Indeed, RT-PCR analysis showed that dbv14 is not transcribed in the Ko dbv4 mutant 
incubated in R3 for 48h. To understand the hierarchy between dbv3 and dbv4, RT-PCR 
analysis of dbv3 was carried out using RNA extracted from Ko dbv4 mutant. This analysis 
revealed that dbv3 is transcribed, demonstrating that Dbv4 does not control dbv3 
transcription (Fig. 27). 
 
 
Fig. 27) RT-PCR analysis of Ko dbv4 RNA using primers for dbv3, dbv4 and dbv14 
genes. D: positive control (DNA); C: negative control (water); *: negative control (-RT). 
 
 
On the other hand, dbv4 is not transcribed in Ko dbv3 mutant grown in R3 for 48 and 72h, 
suggesting a control of Dbv3 on dbv4 transcription (Fig. 28). As a consequence, neither 
dbv14 nor dbv30 are transcribed in ko dbv3 mutant. 
 
 
Fig 28) RT-PCR analysis of dbv4 gene transcription using RNA from wild type 
(lane1), Ko dbv3 (lane2) Ko dbv4 (lane3) and ko dbv6 (lane 4) mutants. 
D: positive control (DNA); C: negative control (water); *: negative control (-RT). 
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Moreover, qRT-PCR of some dbv genes revealed that in the Ko dbv3 mutant transcript 
levels of dbv genes are six - ten fold lower than in wild type (Fig. 29). 
 
 
Fig. 29) qRT-PCR of some dbv genes in Ko dbv3 mutant. 
 
 
 
 
Construction of dbv3 over expression mutant 
 
Analysis conducted on the Ko dbv3 mutant suggested that Dbv3 controls transcription of 
the positive pathway specific regulator Dbv4. Global or pathway-specific regulatory 
factors can be exploited to enhance the production of secondary metabolites. To this end, a 
Nonomuraea strain that over-expresses dbv3 was constructed. pIJ8600, an integrative 
plasmid for Actinomycetes, was used to add a copy of the dbv3 gene in the neutral attB site 
of bacterial chromosome. The genomic integration of pIJ8600-dbv3 in the mutant was 
verified by PCR and Southern blot analysis (Fig. 30). The genome of Nonomuraea has not 
yet been sequenced. After hybridization using pIJ8600 digested with PstI as probe two 
bands of hybridization (about 4,3 and 3,9 kb, lane 1) and four bands (about 6 kb, 4,3 kb, 2 
kb, 800 bp, lane 2) were obtained, as expected. No hybridization signal was detected for 
Nonomuraea wild type (lane 3 and 4). 
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Fig. 30) Southern hybridization of over dbv3 mutant using pIJ8600 digested with PstI. 
Lane 1: Ko dbv3 mutant chromosomal DNA digested with BamHI; lane 2: over dbv3 
chromosomal DNA digested with PstI; lane 3: wild type chromosomal DNA digested with 
BamHI; lane 4: wild type chromosomal DNA digested with PstI; lane 5: marker II; lane 6: 
pIJ8600 digested with PstI. 
 
 
 
A control strain that contains a copy of the empty plasmid was generated. Six clones, 
named 1, 22, 35, 36, 52 and 68, were obtained. The genomic integration of pIJ8600 was 
verified by PCR and Southern blot analysis (Fig.31). After hybridization using pIJ8600 
digested with PvuII as probe three bands of hybridization were obtained, as expected, in 
the case in which the mutant DNA had been digested with PvuII (lane 3-8). No 
hybridization signal was detected for Nonomuraea wild type (lane 2). 
 
 
Fig.31) Southern hybridization of Nonomuraea::pIJ8600 ex-conjugant using PvuII 
digested pIJ8600 as probe. Lane 1 Marker 2; genomic DNA digested with PvuII of wild 
type (Lane 2), and Nonomuraea::pIJ8600 clone 1 (lane 3), clone 22 (lane 4), clone 35 (lane 
5), clone 36 (lane6), clone 52 (lane 7), clone 68 (lane 8); lane 9: 1 kb ladder; lane 11: PvuII 
digested pIJ8600.  
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To value the effect of pIJ8600 integration in Nonomuraea chromosome on A40926 
production, microbiological assays of Nonomuraea::pIJ8600 ex-conjugants were 
performed (Fig.32). The analysis revealed that, in respect to the wild type, four ex-
conjugants produced the same amount of antibiotic (clones 35, 36, 46, 49, 68); one produce 
more antibiotic (clone 22) but standard deviation indicated that this result is not significant; 
one (clone 52) produced lower amount of antibiotic.  
 
 
Fig. 32) Antibiotic production of wild type and Nonomuraea::pIJ8600. 
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Overexpression of dbv3 increases A40926 production 
 
In agreement with results obtained with Ko dbv3 mutant, growth of Nonomuraea wild type 
and over dbv3 mutant in the complete liquid medium R3 is similar: there is a rapid growth 
phase until 72 hours, then a decrease until 140 hours. There is a second growth with a peak 
at 202 hours for wild type and over dbv3 and then the decline phase.  
Microbiological assays showed that wild type begins to produce A40926 at 72 hours, while 
over dbv3 mutant at 54 hours. Moreover, diameter of the inhibition halo was greater in the 
mutant strain compared to the wild type, indicating a higher production of A40926 by over 
dbv3 mutant in respect to wild type. So, dbv3 over expression anticipated and increased 
antibiotic production. In fact productivity, that is the ratio between µg of antibiotic, ml of 
culture and dry weight (grams), was 1,6 fold higher in over dbv3 mutant than in the wild 
type (Fig.33). HPLC confirmed that over dbv3 mutant produced about 2 fold more A40926 
than the wild type strain. 
 
   
Fig. 33) Productivity of Nonomuraea over-dbv3 and wild type after 54, 60, 66, 72 and 
96 hours of growth in liquid R3. 
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Dbv3: transcriptional control of A40926 production 
 
Dbv3 plays a positive role in A40926 production. To evaluate whether Dbv3 acts through 
the activation of the dbv cluster, wild type and over-dbv3 mutant were incubated with and 
without thiostrepton (tio), used as inducer of dbv3 transcription from the TipA promoter in 
the mutant strain. RNAs were extracted from after 54 hours of growth and analysed by 
qRT-PCR.  
qRT-PCR analysis revealed that the addition of thiostrepton did not affect dbv3 
transcription level in wild type (Fig. 32, see wt and wt + tio transcript levels); moreover, in 
over dbv3 mutant dbv3 transcription, induced by adding thiostrepton, was 8 fold higher 
than in the wild type (Fig 34, see wt + tio and over dbv3 + tio transcript levels). 
 
 
Fig. 34) qRT-PCR of dbv3 transcript levels: in Nonomuraea wild type grown with 
thiostrepton (green) and without it (blue) and in the over dbv3 mutant grown with 
thiostrepton (red). 
 
Transcription level of one dbv gene per each poli-cistronic unit was analyzed. Two 
different qRT-PCR were performed: in the first hrdb was used as endogenous; in the 
second one 16s ribosomal RNA was used. All the analyzed genes are from 4 to 20 times 
more transcribed in over-dbv3 mutant in respect to wild type in both analysis. 
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The first qRT-PCR analysis revealed that Dbv3 slightly influences dbv1, dbv14, dbv28, 
dbv4 and dbv6 and strongly controls dbv15, dbv20, dbv26, dbv29, dbv36, dbv37 (Fig. 35). 
  
 
Fig. 35) qRT-PCR. Transcript levels of some dbv genes in over dbv3 mutant in respect 
to Nonomuraea wild type; the values of wt were set equal to 1. hrdb was used as 
endogenous.  
 
The second qRT-PCR analysis (Fig. 36) revealed that Dbv3 slightly influences dbv15 and 
dbv20 (4 fold more transcribed than in the wild type), and strongly controls dbv14, dbv28, 
dbv34 (8 fold) and dbv29 (18 fold).  
 
Fig. 36) qRT-PCR. Transcript levels of some dbv genes in over dbv3 mutant in respect to 
Nonomuraea wild type; the values of wt were set equal 1). 16s was used as endogenous. 
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Both analysis showed that dbv3 is about 10 fold more transcribed in over dbv3 mutant than 
in wild type and an increase in dbv transcript levels in the mutant. The differences between 
the two analysis consisted in the measurement of the increase of expression of individual 
genes: dbv14 and dbv34 are more transcribed in both real time analysis; according the first 
analysis 4 fold, according the second 9 fold more expressed than wild type.  
In general, Dbv3 has a general positive role on most genes of the cluster. The dbv6 and 
dbv7 genes is not affected by dbv3 over expression. 
------------------------------------------------------------------------------------------------------------- 
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Identification of dbv4 transcription start point 
 
The region upstream dbv4 gene consists of 952 nucleotides. To determine the transcription 
start point (TSP) of the dbv4 gene, RNAs were extracted after 24 and 48 hours of growth in 
Rare 3 medium and analyzed by S1 mapping experiment. Analysis demonstrated that dbv4 
transcriptional start site is around 330 nucleotides upstream the translational start site (Fig 
37). The red arrow in figure indicates one of the two timidines that represent the 
transcription start site. 
 
 
 
Fig. 37) Identification of dbv4 transcription start point. 24 and 48 hours lanes represent 
the two samples; P:probe; M: marker; G and T represent the sequenced fragments 
 
 
 
 
 
Identification of an IclR-like protein 
 
Comparative analysis between the upstream region of dbv4 and of the gene encoding the 
Str-like proteins in the cep gene cluster (that specify the biosynthesis of the glycopeptide 
antibiotics chloroeremomycin in Amycolatopsis orientalis) revealed the presence of a 
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common sequence of 43 nucleotides with 73% of identity (5’-
cggagtgatcggaatgctaacgggaagcgttctgcaattcgat-3’) named P4 (Fig. 38). 
 
 
 
Fig. 38) dbv4 upstream region. It contains a conserved sequence of 43 nucleotides 
(underlined) named P4 localized 264 nucleotides upstream the translation start site (the gtg 
codone underlined). TT represent the TSP. 
 
Conserved DNA regions among bacteria could have a functional meaning, i. e. a regulative 
role. The hypothesis is that this region could be a site of binding for positive or negative 
regulators of dbv4 transcription and that this kind of mechanism of regulation is present in 
the cep cluster as well. So, in order to isolate protein/s binding to dbv4 upstream region, P4 
sequence was used as bait in a series of chromatographic steps. 
 
Total proteins of Nonomuraea were extracted after 96 h of growth in RARE3 broth e 
EMSA were performed using P4 fragment as probe (Fig.39). Protein extracts bound P4, 
forming three different complex, indicated in figure as I, II and III complex (low, medium 
and high molecular weight, respectively). The signal of the complex I disappeared only 
when the concentration of cold P4 was 200X (data not shown); the signal of the complex II 
proportionally decreases with increasing specific competitor (lane 3 and 4); intensity of 
complex III remains unchanged with increasing competitor. The three complexes bind in a 
specific manner and with different binding affinities. 
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Fig 39) EMSA of P4 fragment with total protein extracts. I, II and III: low, medium and 
high molecular weight complex respectively 
 
To isolate the proteins of Nonomuraea that bind specifically the P4 fragment, total protein 
extract was fractionated by precipitation with increasing amounts of ammonium sulphate 
concentrations and were subdivided into the three fractions 0-30%, 30-60% and 60-100%. 
The three fractions were used to test binding to the P4 probe in EMSA (Fig 40). 
The analysis showed the formation of different kinds of shift for the fractions 30-60 % 
(complexes II and III, lane 2) and 60-100% (complex I, lane 1). 
 
 
Fig.40) EMSA of P4 with the three protein fractions 0-30%, 30-60% and 60-100% 
fractionated by precipitation with ammonium sulphate. I, II and III: low, medium and 
high molecular weight complex respectively 
 
The samples of the fractions 30-60% and 60-100% were subjected to dialysis and 
fractionated by cation exchange chromatography using FPLC system with columns Mono 
S PC 1.6/5
TM
 (Amersham© Pharmacia Biotech).  
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For the 60-100% fraction, elution of the proteins bound to the column were performed 
(Fig. 41) using five growing concentrations of NaCl: 25% (NaCl 0,25 M), 50% (NaCl 0,5 
M); 75% (NaCl 0,75 M); 100% (NaCl 1 M); 200% (NaCl 2 M). 
  
 
Fig. 41) Cation exchange chromatography of the 60-100% fraction after precipitation 
with ammonium sulphate. Blue line: the signal from the proteins that absorb in 280 nm, 
pink line: signal from the proteins that absorb at 215 nm, red line: the signal from proteins 
that absorb at 254 nm; dark green line: pressure; light green line: discontinuous elution of 
NaCl (step I = 0.25M; step II = 0.50M; step III = 0.75M; step IV = 1 M).  
 
The five fractions were subjected to dialysis and used to test binding to the P4 probe in 
EMSA (Fig.42). All the fractions, except flow trough and protein fraction 25% NaCl (lane 
4 and 5), gave at least one shift. 
 
Fig. 42) EMSA of P4 with the five fractions obtained by cation exchange 
chromatography of the 60-100% fraction (obtained by precipitation with ammonium 
sulphate). I, II and III: low, medium and high molecular weight complex respectively. 
lane1 probe (P4); lane2, crude extract; lane3, 60-100% fraction before chromatography; 
lane4, flow trough; lane5, fraction 25% NaCl; lane6, fraction of 50% NaCl; lane7, fraction 
75% NaCl; lane8, 100% NaCl fraction. 
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The specificity of binding to P4 of the fractions 75%, 100% and 200% NaCl was tested 
using the specific competitor (cold P4). This analysis revealed that the binding was specific 
because the shift signal decreased after addition of the specific competitor (Fig. 43). 
 
Fig 43) EMSA of P4 with the 75%, 100% and 200% NaCl fractions obtained by 
cation exchange chromatography of the 60-100% fraction (obtained by precipitation 
with ammonium sulphate). lane1: probe (P4); lane2: 75% fraction; lane3: fraction 75% in 
presence of 50X specific competitor (P4); lane4: 75% fraction in presence of 200X specific 
competitor; lane 5: fraction 100%; lane 6: 100% fraction in presence of 50X specific 
competitor; lane 7: 100% fraction in presence of  200X specific competitor; lane 8: 200% 
fraction; lane 9: 200% fraction in presence of 50X specific competitor; lane 10: 200% 
fraction in presence of 200X specific competitor. I, II and III: low, medium and high 
molecular weight complex respectively. 
 
The fractions 75%, 100% and 200% have been joined and fractioned into 15 samples by 
cation exchange chromatography with increasing concentration of NaCl (from 50 mM to 2 
M, Fig. 44). 
 
 
Fig. 44) Cation exchange chromatography with increasing concentration of NaCl 
(from 50 mM to 2 M) of the fractions 75%, 100% and 200% have been united into one. red 
line: the signal from proteins that absorb at 80 nm. 
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All the fifteen fractions were used to test binding to the P4 probe in EMSA (Fig.45). Only 
three fractions (samples 6, 7 and 8) gave the low molecular weight shift (complex I). 
 
 
Fig. 45) EMSA of P4 fragment with the 15 protein fractions eluited after Cation 
exchange chromatography with increasing concentration of NaCl. I: low molecular 
weight complex. The asterisks indicate the fractions that gave shift. 
 
The three fractions have been joined and further fractioned into 17 samples by anion 
exchange chromatography (Fig. 46) using columns Mono Q PC 1.6/5
TM
 (Amersham© 
Pharmacia Biotech). 
 
 
Fig.46) Anion exchange chromatography using columns Mono Q PC 1.6/5
TM
 of the 
samples 6, 7, 8 obtained with Cation exchange chromatography. red line: the signal 
from proteins that absorb at 280 nm; light green line: continuous elution of NaCl. 
 
All the fourteen fractions were used to test binding to the P4 probe in EMSA (Fig.47). 
Only one fraction (sample 4, named X1) gave the low molecular weight shift (complex I). 
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Fig. 47) EMSA of P4 fragment the 14 fractions obtained after elution of anion 
exchange chromatography. I and III: low and high molecular weight complex. Tot: total 
protein from Nonomuraea; FT: flowthrought; W: probe. 
 
 
In parallel, the 30-60% fraction (obtained by precipitation with increasing amounts of 
ammonium sulphate) was fractionated by cation exchange chromatography. Elution of the 
proteins bound to the column was performed using growing concentrations of NaCl (Fig 
48). 
 
Fig. 48) Cation exchange chromatography of the 30-60% fraction (obtained by 
precipitation with increasing amounts of ammonium sulphate). red line: the signal from 
proteins that absorb at 280 nm; light green line: continuous elution of NaCl. 
 
 
17 fractions were collected and 12 of these were used to test binding to the P4 probe in 
EMSA (Fig.49). Samples 4 and 5 gave a shift of high molecular weight. Sample 6 and 7 
gave a shift of lower molecular weight. 
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Fig.49) EMSA of P4 fragment with 12 fractions obtained after elution of cation 
exchange chromatography. I, II and III: low, medium and high molecular weight 
complex. Tot: total protein from Nonomuraea; FT: flowthrought. 
 
Protein samples X1 (lane 4, Fig. 47), X2 (lane 4 and 5, fig.49) and X3 (lane 6 and 7, 
fig.49) were then subjected to affinity chromatography by using metal micro-beads 
(MagneSphere Magnetic® by Promega© P4) streptavidin-coated, linked to the biotinylated 
P4 (pull down experiment). After chromatography, the three eluted samples were used to 
test binding to the P4 probe in EMSA (Fig.50). In this ionic condition, all the three samples 
gave the same shift. For each sample, a negative control with beads and total proteins was 
carried out. 
 
 
Fig.50) EMSA of P4 the samples X1, X2 and X3 subjected to affinity chromatography 
by using metal micro-beads. I: low molecular weight complex. S:probe P4; lane 1: 
MagneSphere® and proteins X1; lane 2: MagneSphere®P4 and proteins X1; lane 3: 
MagneSphere® and proteins X2; lane 4: MagneSphere®P4 and proteins X2; lane 5: 
MagneSphere® and proteins X3; lane 6: MagneSphere®P4 and proteins X3. 
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Eluited samples were loaded into a 12% SDS PAGE gel; the gel was silver stained (Fig. 
51) and spots of the single proteins (indicated with a number) were characterized by mass 
spectrometry (LC/MS-MS analysis). In this way the following proteins were identified: 
 Spot 1:   guanosine pentaphosphate synthetase I/polynucleotide phosphorylase  
 Spot 4:   ribonuclease, Rne/Rng family 
 Spot 13: tRNA (adenine-58-N(1)-) methyltransferase  
 Spot 14: transcriptional regulator of the IclR family 
 
 
 
Fig. 51) SDS PAGE of protein fractions isolated by different chromatographic steps. 
The spot number 14, indicated by the red arrow corresponds to an IclR-like protein. 
 
Some of them, like 1, were present in only a sample; others, like 4 and 14, could be present 
in all the three samples. Among the identified proteins, the regulator IclR was the most 
interesting. Thus, qRT-PCR was performed, using RNA extracted from Nonomuraea wild 
type cultivated in a defined growth medium containing either 4.2 or 2 mM phosphate 
(HighP and LowP conditions, respectively). As shown in fig. 9, after 35 h of growth 
A40926 production started in both media, but after 47 h the A40926 yield was different in 
the two phosphate conditions: A40926 was produced in higher amount in LowP condition 
in respect to HighP condition. 
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The qRT-PCR analysis showed that the levels of transcription of genes iclR and dbv4 have 
an opposite trend: iclR was more transcribed when a low yield of antibiotic was produced 
(high phosphate, Fig. 52); dbv4, viceversa, was more transcribed when antibiotic 
production was higher (low phosphate, Fig. 52).  
These preliminary data suggested a possible negative involvement of IclR in A40926 
production. Since the DNA fragment used as bait in pull-down experiments is localized 
downstream the transcriptional start site, a negative role of IclR in dbv4 transcription is 
likely to occur. 
 
Fig. 52) qRT-PCR of iclR e dbv4  Nonomuraea wild type grown on broths called highP 
e lowP. 
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Generation of putative knock out mutant 
 
To further characterize iclR, a strategy to generate an iclR mutant (Ko iclR), by using the 
pIJ773 plasmid, a suicide vector for Nonomuraea, was carried out. An internal fragment of 
the iclR gene was cloned into the plasmid. The integration of the plasmid by single 
crossing over should had led to the interruption of the gene iclR.  
After many attempts, due to the fact that genetic manipulation in this strain is not efficient, 
three putative Ko iclR clones resistant to apramycin were obtained, named heart, star and 
sun. 
 
 
Effect of iclR inactivation in three putative knock out mutants 
 
All the three putative Ko iclR mutants showed some features very different from 
Nonomuraea wild type. On solid V0.1 the mutants grew slowly and lacked of the typical 
pigmentation of Nonomuraea, remaining white even in the late stages of growth. 
Disruption of the iclR gene did not significantly alter growth kinetics in the rich broth R3 
during the first 140 hours of growth (Fig. 53). The differences in growth rate became 
significant later in the growth. 
As negative regulator, we expected to obtain a knock out mutant that produced higher 
amount of antibiotic. Surprisingly, microbiological assays showed that the putative mutants 
produced very late (after 164 hours), while Nonomuraea wild type activated antibiotic 
production at 70 hours. To explain this result we suggested that other pathways could be 
affected by IclR. 
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Fig. 53 Growth of the three putative Ko iclR mutants and Nonomuraea w. t. in R3. 
 
Since IclR was found to be involved in glyoxylate shunt or growth on citrate as carbon 
source, a biochemical characterization of Nonomuraea was carried out. 
Firstly, the glucose concentration in the culture medium was measured at different times of 
growth revealing a different pattern of glucose concentration between the putative Ko iclR 
mutants and the wild type: in fact in the early stages of growth, glucose was not consumed 
by the Knock out mutants, but increased with a peak around 20 hours (Fig.54). After 70 
hours of growth a drastic reduction of glucose was observed in both wild type and star and 
sun mutants; already at 140 hours of growth the concentration of glucose was no longer 
detectable by the instrument used in the laboratory.  
These results suggested that the putative mutants exhibit an alteration in glucose 
metabolism; in particular it would seem that in the early stages of growth the mutants 
strangely do not activate the glucose catabolism, but instead they do gluconeogenesis. 
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Fig. 54 Glucose concentration during growth of the three Ko iclR mutants. 
 
 
On solid V0.1, a poor medium, the mutants grew very slowly. To investigate the metabolic 
pathways which had been altered in the mutant strains, several feeding experiments were 
conducted. 
The addition of leucine, cysteine, methionine and casaminoacids to the minimal medium 
was not sufficient to restore growth and pigmentation in the Ko iclR mutants.  
This suggested that IclR controls other metabolic pathways in Nonomuraea. 
 
Different carbon sources and intermediates of the Krebs cycle were added to the minimal 
medium in order to restore growth kinetic and/or pigmentation (table 2).  
The wild type strain was capable to grow in presence of glucose as sole carbon source, and 
in presence of both glucose and glycerol or glucose and acetate. In contrast, in presence of 
glycerol as sole carbon source, Nonomuraea wild type grows slower, and in presence of 
acetate as sole carbon source, it does not grow, suggesting that Nonomuraea prefers to use 
glucose as carbon source. 
In presence of glucose, mutants showed a slower growth compared to the wild type strain. 
The addition of yeast extract, which is a complex mixture of carbon sources, allowed the 
growth of the mutants with a growth kinetics comparable to wild type. The acetate is not 
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used by all the strains and does not allow growth even in the presence of glucose. In the 
presence of glycerol the wild type strain grows slowly; mutants, however, do not grow 
even when glucose is added to the medium. 
 
 
Table 2 Growth of wild type and ko iclR mutants in Minimal Medium containing different 
carbon sources: Glu: glucose, YE: yeast extract, Gly: glycerol; Ace: acetate; CiT: citrate +: 
growth - growth failure, CR: slow growth. 
 
This suggested that the mutant strains are unable to metabolize glycerol and that the 
presence of glycerol alters uptake and/or metabolism of glucose.  
None of the compounds used restores pigmentation in mutant strains. 
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Construction of iclR over expression mutant 
 
Five mutants of over-expression of the gene iclR (over iclR) were generated. pIJ8600, an 
integrative plasmid for Actinomycetes, was used to add a copy of the iclR gene in the attB 
site of bacterial chromosome. The genomic integration of pIJ8600-iclR in the mutant was 
verified by PCR (Fig. 55) and Southern blot analysis (Fig. 56). 
For the PCR analysis, primers that bind on the two sides of the cloning site of the pIJ8600 
plasmid were used. If pIJ8600 was integrated into Nonomuraea chromosome, a PCR 
product of 700 bp (that is the length of the iclR gene inserted) is expected. In the picture 
55, clones 8, 10, 28, 14, 29, 34 and 33 gave the corret size PCR product (indicated by grey 
arrows). 
 
Fig.55 PCR of over iclR mutants. Genomic DNAs from Clones 8, 10, 14, 28, 29, 33 and 34 
gave the 700 bp PCR product. CP: empty pIJ8600; CN: Nonomuraea wild type. 
 
 
A Southern blot analysis was performed using as probe pIJ8600-iclR digested with PstI 
(fig. 56), a signal at 1,1 kb was detected both in the wild type (lane 3) and in the over iclR 
mutant clone 14 (lanes 4), indicating the hybridization of the wild type copy of iclR gene 
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with the probe. Moreover, another signal is present for the mutants, bigger than 3 kb, 
corresponding to the additional copy of iclR. 
 
 
 
Fig 56) Southern blot analysis of over iclR mutant 14i (lanes 4) and Nonomuraea wild 
type (lane3) DNA digested with PstI, using as probe pIJ8600-iclR digested with PstI (lane 
2). 
 
 
 
 
Effect of iclR over-expression 
 
The five over iclR mutants (8i, 10i, 14i, 29i, 37i) showed morphology, pigmentation and 
growth rates similar to Nonomuraea wild type on R3 agar plates, while in liquid R3 over 
iclR mutants showed a higher rate of growth and a more intense pigmentation than 
Nonomuraea wild type. The microbiological assays revealed that Nonomuraea wild type 
produced A40926 from 72 hours and that none of the putative over-expression mutants 
produced the antibiotic. The absence of antibiotic production in the putative mutants 
suggested that IclR has a negative role in A40926 biosynthesis, and a positive effect on 
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growth; in fact all the mutants accumulated a larger amount of biomass in respect to wild 
type (Fig.57). 
 
 
 
Fig. 57 Growth of Nonomuraea wt and the five over iclR mutants in R3 
71 
 
In vitro binding of His6-tagged IclR 
 
To investigate the activity of IclR, an His6-tagged IclR was prepared. The pRSETB, an 
expression plasmid, was used to insert the iclR gene downstream and in frame with a 
sequence coding for six histidines. The promoter that controls the transcription of the gene 
of interest is the strong promoter for phage T7 DNA polimerase. The construct was 
inserted into the cells of E. coli BL21 AI, in which the transcription of the T7 polymerase 
is inducible by arabinose. The BL21Ai pRSETB-IclR clone was induced with 0,2% of 
arabinose for two hours, when BL21 AI cells at 37 °C reached an O.D6000,6. The His 
tagged IclR protein was purified using Ni-NTA Purification System (Invitrogen). Western 
blotting analysis, using Anti-His G-AP Antibody (invitrogen), confirmed the presence of 
the protein sample eluited with 200mM imidazole (Fig. 58). 
  
 
Fig. 58) SDS page (left) and Western blot analysis (right) of M: Marker, See pre-stained 
standard (Invitrogen); 1: flowthrought; 2: wash1; 3: total proteins; 4: proteins eluted with 
100 mM imidazole; 5: proteins eluted with 200 mM imidazole; 6: proteins eluted with 300 
mM imidazole; 7: proteins eluted with 400 mM imidazole; 8: proteins eluted with 500 mM 
imidazole.  
 
Gel mobility shift assays (EMSA) were carried out using the purified His6-tagged IclR.  
Different DNA probes were prepared. Three probes were obtained by PCR: one contains 
the entire upstream region of dbv4 gene and two contain about half part of the entire region 
and overlap. P4 was prepared by annealing of two oligonucleotides. 
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All these probes were used in EMSA experiments with His6-tagged IclR but no bindings 
were detected. 
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Discussion 
 
The attinomicete Nonomuraea sp. ATCC 39727, genetically and physiologically poorly 
characterized, is known for its ability to produce the antibiotic A40926. The study of the 
morphology and physiology of Nonomuraea can broaden the knowledge of the 
mechanisms of regulation of gene expression and could lead to the understanding of the 
relationships between primary and secondary metabolism. In addition, new knowledge 
would enable the rational handling of Nonomuraea in order to increase production yield of 
the antibiotic A40926. 
In particular, the present study was aimed to elucidate A40926 biosynthesis regulation in 
Nonomuraea sp. ATCC 39727. Thus, we examined the functions of the transcriptional 
regulatory genes, dbv3, dbv4, dbv6 and dbv22 that lie in the A40926 gene cluster in 
Nonomuraea and iclR, whose gene is outside the dbv cluster.  
 
Dbv3 and Dbv4 
Our experiments demonstrated, for the first time, that the transcription activator genes dbv3 
and dbv4 are both required for A40926 biosynthesis. In fact, both Ko dbv3 and Ko dbv4 
mutants have completely lost the ability to produce A40926. 
This study confirmed the function of Dbv4 as a positive regulator of A40926 biosynthesis 
by activating expression of two operons of the dbv cluster: the dbv14-dbv8 operon, 
encoding the four cross-linking oxygenases, the halogenase, the N-acetylglucosamine 
transferase and the N-acylase, and the dbv30-dbv35 operon, encoding the four enzymes 
involved in DPG biosynthesis (Chen et al., 2001; Pfeifer et al., 2001), as well as the 
sodium proton antiporter and a protein of unknown function. Indeed, RT-PCR analysis 
demonstrated that dbv14-dbv8 and dbv30-dbv35 operons are not transcribed in Ko dbv4 
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mutant (Fig.27), confirming that Dbv4 is the pathway-specific regulator in A40926 in 
biosynthesis.  
All the five other gene clusters devoted to glycopeptides (chloroeremomycin, balhimycin, 
complestatin, A47934, and teicoplanin) contain an strR-like regulator (Donadio et al., 
2005). In vitro Dbv4 is able to bind to two palindrome sequence GTCCA (N)17TTGGAC, 
upstream to dbv14 and dbv30 genes while it was clearly unable to bind to its own upstream 
region (Alduina et al., 2007). The bal cluster encodes a Dbv4 ortholog, named Bbr, which 
specifically binds to the upstream regions of five bal genes, including itself (Shawky et al., 
2007) such as StrR controls its own expression (Retzlaff et al., 1995) and probably the 
same occurs in the chloroeremomycin case because in silico analysis indicate the presence 
of StrR binding site upstream the StrR-like gene (Fig. 11, “c” light blue circle). Similarly 
to Dbv4, the StrR-like regulator is not expected to control its own expression in the sta and 
tcp clusters (the upstream regions of StrR- like genes lack of StrR binding site; Fig. 11, “c” 
light blue circle).  
Dbv4 and Bbr, which share 80% identity, possess the same predicted helix-turn-helix motif 
and very similar dimerization domains. Moreover, Bbr is able to bind dbv sequences and, 
vice versa, that Dbv4 recognizes at least some bal sequences (Alduina et al., 2007).  
The dbv cluster appears to contain just two binding sites for Dbv4 while the bal cluster 
contains five Bbr binding sites (Shawky et al., 2007) and the cep, sta, and tcp clusters 
should contain at least two, one, and four predicted Dbv4-binding palindromes, 
respectively (Donadio et al., 2005). In all five clusters, one putative binding site is located 
5’ to oxyA orthologs. This gene encodes the P450 mono-oxygenase responsible for cross-
linking amino acids 2 and 4 (Bischoff et al., 2005). The Oxy enzymes catalyze a critical 
step, probably the most distinctive feature in glycopeptide biosynthesis. Since all 
glycopeptide clusters encode an StrR-like regulator, it is tempting to speculate that 
expression of the oxy genes is controlled in all clusters by the same regulator. 
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To understand the hierarchy between dbv3 and dbv4, RT-PCR analysis of dbv3 revealed 
that dbv3 is transcribed in Kodbv4 mutant, demonstrating that Dbv4 does not control dbv3 
transcription (Fig. 27). 
 
Computer-assisted analysis of the Dbv3 protein revealed that it belongs to LAL (large 
ATP-binding regulators of the LuxR family) family. Dbv3 protein possesses typical LuxR 
family characteristics, including an ATP/GTP-binding domain at the N-terminal and a 
DNA binding helix-turn-helix domain at the C-terminal. The Walker A and B motifs are 
characteristic of a large family of ATPases that have been associated with diverse cellular 
activities, including cell cycle regulation, protein degradation and protein transport. The 
presence of ATP/GTP binding Walker A and B motifs suggests that their activity is 
dependent on ATP/GTP hydrolysis. 
We found that in the Ko dbv3 mutant dbv4 gene is not transcribed (Fig. 28). Moreover, 
qRT-PCR of some dbv genes revealed that  in Ko dbv3 mutant transcript levels of dbv 
genes are six - ten fold lower than in wild type (Fig. 29). According to the data presented 
here, we can suggest that Dbv3 is a transcription regulator that hierarchically acts before 
Dbv4, exerting its control also over the dbv genes. 
Several regulators of the LAL family have been identified in antibiotic and other secondary 
metabolite gene clusters from actinomycetes, including PikD from the pikromycin pathway 
in S. venezuelae (Wilson et al., 2001), RapH from the rapamycin pathway in S. 
hygroscopicus (Aparicio et al.,1996; Kuščer et al. 2007), NysRI and NysRIII from the 
nystatin pathway in S. noursei (Sekurova et al., 2004), and AmphRI and AmphRIII from 
the amphotericin pathway in S. nodosus (Carmody et al.,2004; Caffrey et al., 2008), SsaA 
from the sansanmycin pathway in Streptomyces sp (Li et al., 2013), SanG from 
nikkomycin pathway in Streptomyces ansochromogenes (He et al., 2008), FkbN from 
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FK506 pathway in Streptomyces tsukubaensis (Goranovĭc et al., 2012). All these examples 
of  LAL proteins have are regulator with a positive role in antibiotic production.  
Instead, JadR, a γ-butyrolactone receptor homologue (Wang and Vining, 2003), is a 
repressor gene that negatively regulates jadomycin production in S. venezuelae ISP5230. 
Its disruption led to jadomycin production without environmental stress and increased 
production level when stressed (Yang et al., 1995).  
In this work we demonstrated that Dbv3 is a positive regulator of A40926 production. In 
fact, disruption of dbv3 gene led to loss of antibiotic production; in Ko dbv3 mutant the 
positive regulator dbv4 is not transcribed as well as various genes in the cluster (Fig. 28 
and 29).  
Two LAL regulators in S. coelicolor have recently been identified that control the 
biosynthesis of the blue pigmented antibiotic actinorhodin but also act globally affecting 
various cellular processes, and amongst them the phosphate starvation response (Susana et 
al., 2012). So a pleiotropic role has been recognized to LAL proteins in actinomycetes.  
Disruption of dbv3 did not significantly alter kinetic growth. In fact, the mutants showed 
the same growth rate and morphological characteristics as the parent strain on several 
media (i.e. R3, MS, V01 solid media, or R3 liquid medium) indicating that the dbv3gene is 
not critical for bacterial growth and differentiation. These results suggest that Dbv3 is a 
pathway-specific regulator. 
 
Dbv3 could be a target to increase antibiotic yield. To generate a strains that overproduces 
A40926, a dbv3 over expression mutant was generated, capable to produces earlier and 
more antibiotic than wild type (Fig. 33). So, the impact of overexpression of dbv3 on 
A40926 production confirmed that it is a positive regulator. Interestingly, other dbv genes 
were more transcribed than in the wild type (Fig. 35 and 36). 
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The absence of homology between the upstream regions of all the dbv genes whose 
transcript levels are higher after dbv3 over-expression, suggests that the dbv3 control on 
the cluster could be indirect. Further functional studies of Dbv3 may help to better 
elucidate the regulation of glycopeptide production. 
dbv3 and dbv4 contain one and three TTA codons, respectively, so their expression might 
be dependent also on bldA, the structural gene for tRNA UUA, if this mechanism operates 
in Nonomuraea as well. 
 
IclR 
In experiments of affinity chromatography using as bait a DNA fragment upstream of the 
gene dbv4 (called P4) and then elettroforetic mobility shift assay (EMSA), a protein IclR-
like has been identified (Fig. 51).  
IclR family comprises regulators acting as repressors, activators and proteins with a dual 
role (activator and repressor). Members of the IclR family control genes whose products 
are involved in the glyoxylate shunt (Sunnarborg et al., 1990), multidrug resistance 
(Beinlich et al., 2001; Grkovic et al., 2001; Guazzaroni et al., 2005), degradation of 
aromatics (Tsoi et al.,1999; Romero-Steiner et al.,1994), inactivation of quorum-sensing 
signals (Zhang et al., 2004), antibiotic production (Santamarta et al., 2007; Kim et al., 
2012) and sporulation (Jiang & Kendrick, 2000; Yamazaki et al., 2003; Zhu & Winans, 
1999). 
Since P4 is localized downstream dbv4 transcription start site (Fig. 38, mapped by S1-
mapping experiments, a negative role to IclR was hypothesized. Indeed, qRT-PCR analysis 
showed that the levels of transcription of genes iclR and dbv4 have an opposite trend: iclR 
is more transcribed when a low yield of antibiotic is produced; dbv4, vice versa, is more 
transcribed when antibiotic production is high (Fig. 52). These preliminary data suggested 
a possible involvement of IclR in A40926 production.  
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The morphological and physiological analysis of ko iclR putative mutants reveals that they 
do not grow in minimal medium solid and lack of pigmentation in all the used media. The 
analysis of the growth in rich medium (Fig. 53) shows that the non-pigmentation may not 
be related to a slowdown in the growth stages, but to metabolic abnormalities that need to 
be investigated.  
It is well known that IclR-like proteins are involved in the ability of bacteria to grow in 
certain soils. For example in S. clavuligerus AreB, which gene is located upstream and in 
opposite orientation to the leuCD operon, controls biosynthesis of leucine and of the two 
antibiotics clavulanic acid and cephamycin C (Santamarta et al., 2007). The growth of the 
areB mutant is restored by the addition of leucine to the minimal medium. In S. coelicolor 
Knock out mutant in ndgR, which encodes a IclR-like protein and which is also located 
upstream and in opposite orientation to the leuCD operon, grows in minimal medium only 
after the addition of cysteine and methionine.  
Also in Nonomuraea iclR gene is located upstream and in opposite orientation to the 
leuCD operon (Alifano, unpublished data).  
In order to delineate the metabolic pathways controlled by iclR in Nonomuraea, different 
carbon sources and different amino acids were added to the minimal medium. None of the 
amino acids was sufficient to restore growth and pigmentation in Ko mutants. Further 
feeding experiment are necessary to establish what metabolic pathway was altered in Ko 
iclR mutants. 
IclR seems to be involved in the metabolism of the carbon sources. In fact, the mutant 
strains are unable to metabolize glycerol; interestingly, glycerol seems to alter the uptake 
and /or metabolism of glucose (Table 2). To my knowledge, to date has not yet been 
clarified what carbon sources is preferentially used by Nonomuraea and carbon catabolite 
repression mechanisms have not yet been identified. Here a new model has been suggested 
according to which in the presence of glycerol IclR may act as an activator of the glycerol 
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catabolism. Glycerol also seems to suppress the catabolic pathway of glucose. According 
to this model the glycerol is chosen from Nonomuraea as a favorite carbon source.  
To confirm this hypothesis glucose consumption could be measured during growth in 
liquid minimal medium, in the presence of glycerol or glucose. 
 
Dbv6 and Dbv22 
Microbiological assays suggest that dbv6 could be positively involved in the regulation of 
resistance to the glycopeptides. Dbv6 is a protein VanR-like while Dbv22 could be the 
sensor on the membrane. VanS and VanR are an example of a two-component system, 
identified in pathogenic bacteria resistant to the glycopeptide vancomycin (Hong et al, 
2008). In S. coelicolor it has been shown that VanS and VanR activate the transcription of 
vanHAX genes, for resistance to the glycopeptide antibiotic vancomycin.  
In Nonomuraea Dbv6 could regulate vanY gene transcription, whose product is involved in 
the mechanism of self-resistance. VanY (196 residues) is encoded by the dbv7 gene within 
the dbv biosynthetic cluster devoted to A40926 production. A recent work indicates that 
the MIC of Nonomuraea sp. ATCC 39727 toward A40926 during vegetative growth was 4 
g/ml, but this increased to ca. 20 g/ml during A40926 production (Marcone et al 2010). 
This result indicates that resistance to A40926 is regulated by A40926 production.  
RT-PCR analysis shows that the transcript levels of dbv6 and dbv22 genes are constant 
over time (Alduina et al., 2007). Therefore it can be assumed that the dbv6 and dbv22 
genes are constitutively transcribed; in the presence of an inducer molecule (which may be 
the same antibiotic) Dbv22 could activate Dbv6 by phosphorylation and Dbv6 could 
activate vanY transcription. 
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Materials and Methods 
 
Bacterial strains, cloning vectors and cultivation 
Nonomuraea strains ATCC 39727, Ko dbv4, Ko dbv3 and over dbv3 were cultured in R3 
medium and plated on R3 (Shima, 1996), V0.1 (Marcone, 2010), MS (Kieser, 2000). 
Escherichia coli DH10B (Invitrogen) was used as general cloning host. E. coli ET12567 
[pUZ8002] was used as donor in intergeneric conjugations (MacNeil, 1992). E. coli 
BW25113 (Datsenko, 2000) was used as the host for Red recombination. The integrative 
vector pIJ8600 was used for gene over-expression. Antibiotic assays were carried out 
against Micrococcus luteus ATCC 9341 (Kovacs, 1999). 
All flask cultures were incubated at 30°C on a rotary shaker (200 rpm), using 250-ml 
baffled flasks. Frozen cell stocks of the parent and the mutant strains were prepared by 
storing at −80°C individual aliquots of the desired strain from mid-exponential cultures in 
medium R3. Seed cultures were prepared by inoculating 0,2 ml of the frozen cell stock into 
20 ml of fresh R3 medium, which was incubated for 120 hours, before transferring 1 ml 
into 50 ml of fresh R3 medium. Aliquots at different time points were taken and stored at -
80°C.  
For HPLC analysis, samples were mixed with 2 volumes of methanol, mixed briefly, 
followed by 1 h incubation at 40°C. After centrifugation to remove cells, the clear 
supernatant was used for high performance liquid chromatography (HPLC) analysis.  
 
Genetic procedures 
Standard genetic techniques with E. coli and in vitro DNA manipulations were as 
described by Sambrook, Fritsch and Maniatis ( 1989). 
Recombinant DNA techniques in Streptomyces species and isolation of Streptomyces total 
DNA were performed as described by Kieser (2000). Southern hybridization was carried 
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out with probes labeled with digoxigenin by using the DIG DNA labeling kit (Roche 
Biochemicals). Intergeneric conjugation between E. coli ET12567 [pUZ8002] and 
Nonomuraea strains was performed as previously described (Stinchi et al., 2003). 
 
Construction of Knock out mutants 
Deletion of dbv3 and dbv4 from Nonomuraea was made by replacing the wild-type gene 
with a cassette containing an apramycin selective marker using a PCR based system 
(Kieser 2000). The plasmid pIJ773 containing the apramycin resistance gene (aac(3)IV) 
and the oriT replication origin was used as a template. The knock out mutant in dbv3 was 
constructed using the oligonucleotides dbv3 tar for and dbv3 tar rev (see table 1). The 
knock out mutant in dbv4 was constructed using the oligonucleotides dbv4 tar for and dbv4 
tar rev. 
These long PCR primers were designed to produce a deletion of dbv4 gene from 39 bp 
downstream its start codon to 41 bp upstream its stop codon and respectively 98bp and 
53bp for dbv3 gene. 
The 39 sequence of each primer matches the right or left end of the disruption cassette (the 
sequence is shown uppercase in both primers). The extended resistance cassette was 
amplified by PCR and E. coli BW25113/pIJ790 bearing cosmid 11A5 (Sosio et al., 2003) 
was electro-transformed with this cassette. The isolated mutant cosmid was introduced into 
the non-methylating E. coli ET12567 containing the pUZ8002. The mutant cosmid was 
then transferred to Nonomuraea ATCC 39727 by intergeneric conjugation. Double cross-
over conjugants were screened for their apramycin resistance and analyzed by PCR, using 
respectively the primers Ko dbv3 for and Ko dbv3 rev to confirm Ko dbv3 mutant, and Ko 
dbv4 for and Ko dbv4 rev to confirm Ko dbv4 mutant. The PCR products were sequenced 
(BMR Genomics). 
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Construction of over dbv3 mutant 
The integrative vector pIJ8600 was used for dbv3 gene over-expression. PCR fragment 
was prepared using the primers over dbv3 for and over dbv3 rev, cloned into pGEM T-
Easy vector (Promega), digested with BglII (Invitrogen) and NdeI (Invitrogen). This 
fragment was cloned into the BamHI (Invitrogen) and NdeI site of pIJ8600. The plasmids 
were transferred to Nonomuraea by conjugation from E. coli ET12567 [pUZ8002] as 
described previously. A control strain was prepared by transferring pIJ8600 to 
Nonomuraea. 
 
Nucleic acid extractions 
RNA was extracted using the RNeasy® midi Kit after 48 and 72 h of growth. Briefly, four 
ml from liquid cultures were harvested by centrifugation; and frozen at -80°C. The 
mycelium was then added to P buffer (Kieser, 2000). in the presence of lysozyme 
(50mg/ml). RNeasyMini Spin columns were used for RNA isolation according to 
manufacturer’s instructions. RNA preparations were treated twice with DNase I (Roche) in 
order to eliminate chromosomal DNA contamination. The absence of DNA was confirmed 
by PCR with recombinat Taq DNA polymerase (Invitrogen). Total RNA concentration was 
determined with a NanoDrop ND-1000 spectrophotometer (Thermo Scientific), and quality 
and integrity were checked in an agarose gel. 
 
Gene expression analysis by Reverse Transcriptase PCR 
Transcription was studied by using the SuperScriptTM One-Step RT-PCR system with 
PlatinumH Taq DNA polymerase (Invitrogen), using 100 ng of total RNA as template. 
Conditions were as follows: first strand cDNA synthesis, 50°C for 30 min followed by 
95°C for 10 min; amplification, 30 cycles of [95°C for 30 sec, 66°C for 30 sec, and 72°C 
for 30 sec]. Primers (18–25 mers,) were designed to generate PCR products of 
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approximately 200–500 bp. Negative controls were carried out with each set of primers 
and PlatinumH Taq DNA polymerase in order to confirm the absence of contaminating 
DNA in the RNA preparations. 
 
qRT-PCR 
RNAs were converted in cDNAs using High Capacity cDNA Reverse Transcription Kit 
(Applied Biosystems) and 100 ng of total RNA as template. Power SYBR
®
 Green (Applied 
Biosystems) was used for qRT-PCRs, and reactions were run on a Applied biosystem 7300 
Real-time PCR System (Applied Biosystems). Reactions were carried out by triplicate and 
appropriate controls were included to verify the absence of gDNA contamination in RNA, 
and primer-dimer formation. Primers were designed to generate PCR products between 
200 and 350 bp. The PCR reactions were initiated by incubating the sample at 95°C for 10 
min followed by 40 cycles at 95°C for 15 s, 64°C for 60 s. The expression of the 
Nonomuraea hrdB gene, likely to encode a constitutive vegetative sigma factor or 16S 
RNA, were used as an internal control to quantify the relative expression of target genes. 
To check the specificity of qRT-PCR reactions, a DNA melting curve analysis was 
performed by holding the sample at 60°C for 60 s followed by slow ramping of the 
temperature to 98°C. SYBR fluorescence was normalized by ROX fluorescence. 
 
Microbiological assay for A40926 production 
A dense suspension of Microccoccus luteus was prepared in sterile water at the 
OD600=1.2. 
Transfer 100 µl of bacterial suspension in a falcon with 7ml of soft agar and pour on a 
plate of LB agar. When the soft agar becomes solid, pieces of 3MM paper containing 
supernatants of cultures were added. 
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Feeding experiments 
Sources of carbon added to 20 ml of minimal medium: 
625 µl of 40% glycerol in order to obtain a final concentration of 1% glycerol; 
500 µl of a solution obtained by dissolving 1g of yeast extract, 5 ml of water (0.1 g of yeast 
extract per 20 ml of minimal medium); 
40 µl of 1M citric acid (final concentration); 
20 µl of 3M sodium acetate in order to obtain a final concentration of 0.3 10-3M. 
 
S1 mapping high resolution 
Probe was generated by PCR: the downstream primer 4_DWnew was phosphorylated 
using γ32P and T4 polynucleotide kinase; the PCR was performed using the radiolabelled 
primer and the unlabeled upstream primer. To differentiate probe-probe reanniling and full 
length protection, the upstream primer was incorporate with a non-homologous tail at the 
5’ end. Then 40 µg of RNA and 30 fmole probe were mixed together , dry in speed 
vacuum and resuspended in 20 µl of NaTCA hybridization solution (Summerton, 1983). 
The tube was placed in a 70°C bath for 10 minutes and transferred at 45°C for 15 hours. 
300 µl of chilled 5x S1 digestion buffer (1,4 M NaCl; 150 mM sodium acetate pH4.4; 22,5 
mM zinc acetate; 100 µg/ml denatured non homologous DNA) containing 100 units S1 
nuclease was added to the tube and then it was placed in ice. The sample was incubated at 
37°C for 45 minutes and 75 µl of S1 termination solution (2,5 M ammonium acetate, 
0,05M EDTA) were added to the sample. 10 µg of carrier tRNA and 400 µl of isopropanol 
were added to the sample and after 10 minutes on ice, it was spinned and pellets were 
resuspended in S1 loading buffer (80% formamide, 10 mM NaOH, 1mM EDTA, 0,1% 
bromophenol blue). After denaturation (90-100°C for 2 minutes), run was performed on a 
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conventional 6% polyacrylamide-urea sequencing gel, alongside an appropriate sequencing 
ladder. The gel was exposed to X-ray film. 
 
Total Protein extraction 
The cells after 96 hours of growth in Rare 3 were resuspended in crack buffer (10 mM 
Tris-HCl [pH 8.0], 0.5 mM EDTA, 0.3 mM DTT) in a volumetric ratio of 1:1 and were 
then lysed by sonication (using the ultrasonic generator Vibra-cell, Sonic & Material) with 
four pulses of 30 seconds (% duty cycle: off, output control: 4). The suspension was 
centrifuged at 12,000 rpm for 15 minutes at 4° C and the spent medium was recovered and 
stored at -80°C (termed crude extract). 
 
Fractionation by precipitation in ammonium sulfate 
The total of (NH4)2SO4 with which to treat the crude extract was added slowly and the 
samples were incubated  at 4°C for one hour in ice and the centrifuged at 10,000 rpm for 
10 min in tubes corex. The pellets were resuspended in 4 ml of water milliQ sterilized and 
stored at -80 ° C. The procedure was performed three times, namely those required to 
subdivide the crude extract in three ranges of ammonium solfato : 0-30% , 30-60 % and 
60-100%. To determine the amount of ammonium sulphate , needed to reach a certain 
saturation percentage , was applied to the following formula :  where S1 is the 
saturation percentage of the initial solution , S2 is the percentage of saturation of the final 
solution, and G is the weight in grams of ammonium sulfate to add to a liter of solution. 
To 5 ml of crude extract were added 0.7995 g of (NH4) 2SO4 . The amount of ammonium 
sulfate added to cover the subsequent saturation was determined in based on the volume of 
the supernatant, which is subject to change after the first addition the first aliquot of 
ammonium sulfate. The fractions from the ammonium sulfate precipitation were dialyzed 
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using the dialysis membranes NeflexTM (Union Carbide©). The samples were inserted 
into dialysis membranes and dialyzed against distilled water for one hour. The procedure 
was repeated two more times and then over night.  
 
Preparation of double-stranded oligonucleotides 
The preparation of the oligonucleotide double-stranded P4 of 43 bp, biotinylated 
not, was made from the single-stranded filaments : 
FOR: 5'ATCGAATTGCAGAACGCTTCCCGTTAGCATTCCGATCACTCCG3 ' 
REV: 5'CGGAGTGATCGGAATGCTAACGGGAAGCGTTCTGCAATTCGAT3 ' 
The oligonucleotides were resuspend in H20 to obtain a final concentration of 2 g/L. Equal 
amounts of the two complementary oligonucleotides (25 to 100 g) were mixed in Buffer M 
Boehringer©, for a final volume of 200 μl. This mix was boiled for 5 minutes, then cool 
down slowly to 4°C and the probe was purified on a 20% non-denaturing polyacrylamide 
gel. The gel portion of the gel containing the oligonucleotide double-stranded was taken 
with a scalpel, placed in a eppendorf tube and DNA was eluited from the gel according to 
the crush- soak method (Sambrook J. et al., Molecular Cloning : a Laboratory Manual, 
1982). The DNA was resuspended in sterilized milliQ H2O. 
The marking of the oligonucleotide double-stranded P4 has provided for the use of T4 
polynucleotide kinase (Invitrogen ™) and has complied with the protocol of the supplier. 
For purification from excess nucleotides have been used columns MicroSpin™ G-25 
Columns (GE Healthcare, Amersham©). 
 
Affinity chromatography 
For the affinity chromatography that uses the biotin-streptavidin system and as resin 
marbles metal MagneSphere® Magnetic Promega© (1 mg/ml) P4 DNA was used at a 
concentration of 30 ng/L. The protein fractions have been used to concentration of 0.2 
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mg/ml in Lysis Buffer, together with 1mM PMSF (protease inhibitor) and poly d(I)-d(C) or 
alternatively in Lysis Buffer and poly d(I)-d(C). 
Aliquot 200 μl of MagneSphere Magnetic® were prepared in three 1.5 ml tubes : A, 
control only MagneSphere®; B, control and extract only MagneSphere® protein; C, 
samples with MagneSphere®, DNA and protein extract. The three mixes were incubate for 
2 minutes in a magnetic rack, the supernatant was removed and MagneSphere® were 
resuspended  in 100 µl of Wash Buffer 2X. This wash was repeated three times. At the end 
MagneSphere® were resuspended in 200 μl of Wash Buffer 2X. 200 μl of sterilized milliQ 
H2O was added in the samples A and B, and 200 μl of DNA in the sample C. the samples 
were incubated 2 minutes into a thermo mixer at 22°C, mixed manually every 5 minutes to 
resuspend the MagneSphere®, incubated for 2 minutes in a magnetic rack. The supernatant 
was removed and MagneSphere® were resuspended in 1 ml of 1X Wash Buffer. This wash 
was repeated three times. MagneSphere® of sample A were resuspended in 600 μl of Lysis 
Buffer; samples B and C in 600 μl of protein sample. The samples were incubated 2 hours 
at 22°C in thermo mixer, shaked manually every 20 minutes to resuspend the best 
MagneSphere. The samples were incubated for two minutes on a magnetic rack, the 
supernatant (which contained the unbound protein fraction) was recovered and 
MagneSphere® were resuspended in 50 µl of Elution Buffer and incubated for 10 minutes 
at 22°C in a thermomixer. After incubation for 2 minutes in a magnetic rack and the 
supernatant (eluate) was recovered. At the end of each incubation in thermo mixer is 
possible to subject the samples to a mild centrifugation at 500-1000 rpm for 10-15 seconds. 
 
Ion exchange chromatography 
The ion exchange chromatography uses a FPLC system. Mono Q PC 1.6/5™ (Amersham 
Pharmacia Biotech) columns of 1 ml were used. The samples were filtered through a filter 
of 0.22 mM and then loaded into the column. For loading and elution were used two 
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buffers: 0.05 M Hepes+NaCl, 0.05 M Hepes pH 8 and 0.05 M NaCl+1M pH8. The 
relationship between the two buffers, which determines the final concentration of the 
eluent, is finely adjusted through a computerized system that controls the concentration of 
high-salt buffer and the flow rate (1 ml/min). The liquid exiting from the column reaches a 
detector (AUSF: 0.02), which will draw a chromatogram. 15 fractions were collected using 
increasing concentrations of NaCl from 0.25 M to 2M. The protein fractions, because of 
the high salt concentrations, were dialyzed against Distilled H2O, before being subjected to 
other analysis. 
 
EMSA 
For electrophoretic mobility shift assays (EMSA) non-denaturing 5% polyacrylamide gel 
were used. The polymerization took place under the hood chemistry in a chamber formed 
by electrophoretic glasses 17X16 cm 3 mm thickness and spacers of 1.5 mm. 
10 μl of protein sample was thawed slowly on ice, incubated for 20 minutes in ice together 
with 2 μl of sterilized milliQ H2O, 2 μl of 50% glycerol, 2 μl of 10X BB (binding buffer), 1 
μl of 10 mM MgCl2, 1 μl of poly d(I) - d(C) (Nonspecific DNA). After that, the probe was 
added (P4 labeled with γ32 -ATP) to concentration of 0.2 ng/L and the mixture was 
incubated for 15 minutes on ice. The running was conducted at 160 Volts and 20mA. The 
running buffer is the 0.5X TBE. The gel was removed from the electrophoretic chamber, 
adsorbed to a sheet of 3 mm paper and dried over Gel-dryer at 80°C for 1 hour. Once dried, 
the gel was exposed against an autoradiographic film, for the desired time. The 
autoradiographic film has been developed and fixed in the darkroom thanks to Kodak 
reagents. Subsequently was made to dry at 37° C for 30 minutes. 
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Table 4. Primers used in this work 
 
primer name primer sequence use 
16s nono left AGCTTGTTGGTGGGGTAGTG 
endogenous control in qRT-PCR 
16s nono right TCACCGCTACACCAGGAATT 
hrdb rev CTGGCGGATGCGCTCACGCGTGAC 
endogenous control in qRT-PCR 
hrdb for CTCGCTGGCCAAGCGCTACACCGG 
dbv3 rt rev GCCGGCTGGACGTGAAGGTGA 
qRT-PCR of dbv3 gene 
dbv3 rt for CGACACTCCGCCCAGCAGCAG 
dbv4 rt rev GCTCCAACCGGCCTCTCACATC 
qRT-PCR of dbv4 gene 
dbv4 rt for GGGGTGAAACAACAATCTCGGTGA 
dbv6 rt for AGCCTGGGCGCCGACGACTAT 
qRT-PCR of dbv6 gene 
dbv6 rt for GCGCGGGACGGTTTCGATCA 
dbv14 rt rev AGCATGTCGTCGCCGGGATC 
qRT-PCR of dbv14 gene 
dbv14 rt for GGTGCTGGGCTCGGACAAGTTC 
dbv15 rt rev GATGAGACTCTTCGGCCGGATGT 
qRT-PCR of dbv15 gene 
dbv15 rt for CGGCTCCTTCCTCGTGCTCGT 
dbv20 rt rev GCCGCTGATCGAGGAACGCC 
qRT-PCR of dbv20 gene 
dbv20 rt for CGCCCGAATCGTGTCATGAA 
dbv26 rt rev CGCCCGAATCGTGTCATGGAA 
qRT-PCR of dbv26 gene 
dbv26 rt for GCCGCTGATCGAGGAACGCC 
dbv28 rt rev TCCGCTACTGGGGGCACGC 
qRT-PCR of dbv28 gene 
dbv28 rt for CGGCGGATATGGCGGTAGAGAA 
dbv29 rt rev CCCGCTGTTCCGCTCGTACCA 
qRT-PCR of dbv29 gene 
dbv29 rt rev CCTGATCGAGCCGGGCAACAC 
dbv34 rt for CGGCCAGGACCTCAAGGAACG 
qRT-PCR of dbv34 gene 
dbv34 rt for GGCCACCGACCGATCCAGCT 
dbv36 rt rev CGGGCAGGACGTGGCAGGAG 
qRT-PCR of dbv36 gene 
dbv36 rt for CGGGCACAGTATGGGCAGTTTG 
dbv37 rt rev ACCGCCTCCCCACGCTGAAG 
qRT-PCR of dbv37 gene 
dbv37 rt rev CGGGTTGAGCAGGCTGATCGAC 
left ko2 iclR GGTGATGAACGGGTCTGC 
qRT-PCR of iclR gene 
left ko1 iclR TTCACTGGCTCAGCTCGTC 
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primers name primers sequence use 
dbv3-apra for 
 
GCCGGCCGCGGTGGAGTGGGCGTCATCAC- 
GGGGCCTGTGATTCCGGGGATCCGTCGACC 
 to generete Ko dbv3 mutant 
dbv3 apra rev 
CCTCACGCGGCTCGCGGCCGGCTGTGGCCGT- 
CGCCTTCTTGTAGGCTGGAGCTGCTTC  
 
dbv4-apra for 
 
GTGGACCCGACGGGAGTTGACATAGCCAC- 
TCTCCCTGTCATTCCGGGGATCCGTCGACC 
 to generete Ko dbv4 mutant 
dbv4 apra rev 
AGCGGCCAGATCGGTCGCCCGCCCCTCCA- 
GGCGATCCGCTGTAGGCTGGAGCTGCTTC 
 
dbv6-apra for 
 
ATGCGCGTTCTGGTGGTGGAGGACCAAGT- 
CGACCTGGCCATTCCGGGGATCCGTCGACC 
 to generate Ko dbv6 mutant 
dbv6 apra rev 
ATGCGATATCCCTCGCGCGGGACGGTTT- 
CGTCGCCTTCTTGTAGGCTGGAGCTGCTTC  
 
dbv22-apra for 
 
GTGGCCCATCGTCTCCGACGCCTGACAA- 
CAGCCTTCCGCATTCCGGGGATCCGTCGACC 
 to generate Ko dbv22 mutant 
dbv22 apra rev 
GGATGGCGCCAGCCGGCGCAGCGCGCGCC- 
GCATGAGGGGTGTAGGCTGGAGCTGCTTC 
 
Ko iclR rev AAGCTTGTGCAGCCGGTCGGGCTCCT 
to generate Ko iclR mutant 
Ko iclR for  AAGCTTCAATGCCCTGGAAGCGGGAC  
dbv3 tar rev TCACAGCAGATTCCGGTACA 
to distinguish Ko dbv3 mutant from wild type  
dbv3 tar for GATGAGCACGAGTGGATGAG 
dbv4 tar for ACTTGGCCGATCGATTTATG 
to distinguish Ko dbv4 mutant from wild type  
dbv4 tar rev GAATCGAGCAACCTCGTCAG 
dbv6 tar for ACGCGAGCTATGGTGTCAG 
to distinguish Ko dbv6 mutant from wild type  
dbv6 tar rev GCTTCTCCTCATCCCTCTCC 
dbv22 tar for GTGCGCTGACTCGGTAGG 
to distinguish Ko dbv22 mutant from wild type 
dbv22 tar rev ACGTTCTCTGACCAGCCTGT 
f_dbv3 (NdeI):    AAAAAAAACATATGCTGTTCG GGCGAGATCG 
to generate the over dbv3 mutant 
r_dbv3 (BglII): AAAAAGATCTCTACAGCCGCACTGCCTCAC 
f_iclR(NdeI) AAAAAAAACATATGTCGAGACTGCAGTATCG 
to generate the over iclR mutant 
r_iclR(BamHI) AAAGGATCCTCATGACGTGCGGCGCATCG 
iclR-BamHI GGATCCAATGTCGAGACTGCAGTATCG to overexpress 6 his tagged IclR in E. 
coli iclR-HindIII  AAGCTTTCATGACGTGCGGCGCATCG 
pIJ8600 r TCACTCCGCTGAAACTGTTGA 
to amplified insert in pIJ8600 
pIJ8600 l GGTTGGACAGGGCTGAGG 
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